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INCREASING BLOOD GLUCOSE MONITORING IN ADOLESCENTS
WITH TYPE 1 DIABETES: EFFECTS OF A PROMPT

Stephen J. Albrecht, Ph.D.
Western Michigan University, 2005

A series of single-subject designs (AB, ABAB) were used to assess the effects of
an antecedent prompting procedure (i.e., prompts) on blood glucose monitoring in young
individuals diagnosed with type 1 diabetes. Prompts were delivered through portable,
automated paging technology. Frequency of blood glucose checks was obtained across
meter, baseline, and intervention phases. Metabolic control was assessed by obtaining
blood glucose levels for each check across baseline and intervention phases, and
hemoglobin (HbAic) values at study entry and follow-up. Results indicated that the
prompt increased blood glucose monitoring for three participants, and metabolic control
improved for 2 participants when the prompts were used. Results also indicated that
telephone contacts used in this study led to modest improvements in blood glucose
monitoring, which may have attenuated the intervention effects for 2 participants. Efforts
to gradually reduce the frequency of prompts while maintaining adequate rates of blood
glucose monitoring were partially successful for 1 participant. Findings from this study
suggest that prompts delivered through automated paging technology has the potential to
improve blood glucose monitoring and metabolic control in the short-term among young
individuals diagnosed with type 1 diabetes.
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Introduction
The pediatric literature shows that many children and adolescents diagnosed with
a chronic medical condition may experience problems adhering to their prescribed
medical regimen, which in turn may adversely affect both their physical and
psychological well-being. Medical conditions that require intensive and complex
treatment regimens include, but are not limited to, asthma, cystic fibrosis (CF), sickle cell
disease (SSD), juvenile rheumatoid arthritis (JRA), and type 1 diabetes. Each of these
conditions requires adherence to a detailed, prescribed regimen in order to maximize
effective management of the medical condition. Unfortunately, many pediatric patients
diagnosed with these conditions fail to adhere to their prescribed medical regimens
(Rapoff & Christophersen, 1982; Johnson et al., 1982; Kovacs, Goldston, Obrosky, &
Iyengar, 1992).
A substantial number of research studies have documented high rates of treatment
non-adherence found among these groups of patients (Baum & Creer, 1986; Johnson et
al., 1982; Kovacs, Goldston, Obrosky, & Iyengar, 1992; Litt & Cuskey, 1980; Rapoff &
Christophersen, 1982; Vami & Jay, 1984). The overall non-adherence rate for pediatric
patients with chronic medical conditions is approximately 50% (Rapoff &
Christophersen, 1982; Litt & Cuskey, 1980). In terms of type 1 diabetes specifically, non
adherence rates to one treatment component of the medical regimen (i.e., monitoring of
blood glucose levels) fall between 30% and 80% (Johnson et al, 1982; Kovacs, Goldston,
Obrosky, & Iyengar, 1992). Pediatric patients who fail to adhere to their prescribed
medical regimen may place themselves at a greater risk for developing long-term,
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negative health consequences. Moreover, higher rates of treatment non-adherence may
indirectly increase overall health-care utilization costs and rates (Rapoff, 2001).
Over the past two decades, numerous studies have investigated the prevalence,
correlates, and negative consequences of treatment non-adherence. However, relatively
fewer studies have focused on the actual development of effective intervention strategies
for improving treatment adherence in patients with chronic medical conditions (La Greca
& Schuring, 1995; Lemanek, Kamps, & Chung, 2001; Rapoff, 2001). Several empirical
reviews of the extant literature have concluded that the development and investigation of
methods of enhancing treatment adherence for many chronic medical conditions are
sorely needed (Drotar & Lemanek, 2001; Holden, Deichmann, & Levy, 1999; Janicke &
Finney, 1999; McGrath, Mellon, & Murphy, 2000; McQuaid & Nassau, 1999; Mellon &
McGrath, 2000; Powers, 1999; Walco, Sterling, Conte, & Engel, 1999). In today’s
environment of managed health care, it is also imperative that in developing these
interventions, attention is paid to ensuring that the interventions are cost-effective, timeefficient, and relatively easy to implement in the context of the general medical setting
(Rapoff, 2001).
With the emergence of more advanced medical treatments and technology, health
care professionals have developed more complex and sophisticated medical regimens (La
Greca & Schurman, 1995). For example, innovative technology has allowed patients with
type 1 diabetes to use an electronic device (i.e., blood glucose monitor) to monitor their
blood glucose levels from home. Technological advances such as home-based blood
glucose monitors have vastly improved the quality of treatment for patients with chronic
medical conditions; however, they have also indirectly increased the complexity of

2
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medical regimens. As more complicated medical regimens are being developed, health
care professionals will place increasing demands and expectations on pediatric patients
and their families for more consistent adherence to the prescribed regimen (La Greca &
Schuman, 1995).
Pediatric psychologists are in a unique position to deal with these new demands
and challenges for increased treatment adherence to complex medical regimens.
Psychologists have the unique knowledge, skills, and training in conducting applied
research and intervention design to enhance treatment adherence (Drotar, 1995; Kelleher,
1999; Perrin, 1999; Wertlieb, 1999). With these new challenges, it has become vital for
psychologists to familiarize themselves with the various medical regimens, participate on
multidisciplinary health care teams, and to develop collaborative relationships with other
health-care professionals (Drotar, 1995). Since many patients are at-risk for developing
serious health complications, ongoing collaboration with the health care team throughout
the research project is essential to overcome various practical issues often encountered in
real-world medical settings. Because of the rapid development of medical technology, it
will be also crucial for pediatric psychologists to begin exploring how they can integrate
modem medical technology with their intervention methods and research outcomes.
In this study, we were specifically interested in improving treatment adherence
among young patients diagnosed with type 1 diabetes. Using portable, automated paging
technology, we developed an antecedent prompting procedure designed to increase the
frequency of blood glucose monitoring in patients with type 1 diabetes. More
specifically, external prompts for blood glucose monitoring were delivered through
automated paging technology. Although portable paging technology is relatively

3
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expensive, many medical settings already have preexisting paging system capability.
Consequently, automated paging technology may prove to be a cost-effective and timeefficient intervention for improving treatment adherence to complex medical regimens.
Types of Diabetes
The two main forms of diabetes that occur in the United States are Type 1 and
Type 2 diabetes (Kenny, Aubert, & Geiss, 1995). Type 1 diabetes, which will be the
primary focus of this review, is also referred to as Insulin-Dependent Diabetes Mellitus
(IDDM). Type 1 diabetes is typically diagnosed in early childhood or less frequently, in
the adolescent years. Due to pancreatic failure, patients with type 1 diabetes are unable to
produce insulin, an important endogenous hormone needed to break down glucose in the
bloodstream (Johnson, 1995). Without insulin, glucose is unable to move from the
bloodstream into the cells (i.e., muscle, brain) where it is needed for energy.
Consequently, patients with type 1 diabetes are required to administer daily injections of
exogenous insulin to maintain blood glucose levels within the normal range (Silverstein,
1994). Type 2 diabetes, also known as Non-Insulin Dependent Diabetes Mellitus
(NIDDM), is diagnosed more frequently in older adult populations, although the extant
literature is documenting an alarming and increasing trend among younger individuals
(Rubin & Peyrot, 2001). With type 2 diabetes, the pancreas produces insulin, but not in
adequate amounts to keep blood glucose levels within the normal range. Since patients
with type 2 diabetes produce small amounts of endogenous insulin, patients can control
their blood glucose levels by closely monitoring their diet, obtaining plenty of physical
exercise, reducing body weight, and taking oral medications (Johnson, 1995; Rubin &
Peyrot, 2001).

4
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Epidemiology
Type 1 diabetes affects approximately 1 in 600 school-age children (LaPorte &
Matsushima, & Chang, 1995; LaPorte & Tajima, 1985; Silverstein, 1994). The risk of
developing type 1 diabetes is much greater than a number of other well-known childhood
chronic diseases, including childhood cancer, juvenile rheumatoid arthritis, cystic
fibrosis, and muscular dystrophy (LaPorte & Cruickshanks, 1985). Research has also
demonstrated that Caucasian American children are 1.5 times more likely to develop type
1 diabetes than African American children (LaPorte & Cruickshanks, 1985; Zimmet,
1983). However, for those children with type 1 diabetes who are of African-American
descent, recent research shows that they have poorer metabolic control and higher
hospitalization rates (Auslander, Anderson, Bubb, Jung, & Santiago, 1990; Delamater,
Albrecht, Postellon, & Gutai, 1991; Delameter et al., 1999).
Etiology
The etiology of type 1 diabetes has not been clearly established, although many
genetic researchers have hypothesized that the immune response genes HLA-DR3 and DR4 are implicated in the development of this medical condition (Wolf, Spencer, &
Cudworth, 1983). However, only 1 in 50 offspring of parents with type 1 diabetes will
develop the condition before the age of 20 (Laporte & Cruickshanks, 1985). Moreover,
when examining concordance rates, only 60% of identical twins will both develop type 1
diabetes (Barnett, Eff, Leslie, & Pyke, 1981). More recently, researchers speculate that an
autoimmune process, which destroys insulin-producing islet cells within the pancreas, is
a possible triggering mechanism for developing type 1 diabetes. However, the factors that
trigger this mechanism have not been clearly identified (Thai & Eisenbarth, 1993).

5
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Medical Treatment of Type 1 Diabetes
The medical regimen for type 1 diabetes is complex and involves multiple
treatment components (Peyrot, McMurry, & Kruger, 1999; Rubin & Peyrot, 2001). The
regimen requires patients to make a number of significant life-style changes, including
following strict dietary guidelines, obtaining plenty of physical exercise, and scheduling
insulin injections and blood glucose checks in a timely manner (Johnson, 1995). In
addition, patients are encouraged to control or minimize other well-known factors that
have been found to affect metabolic control, including physical illness, negative
emotional states, and stress (Johnson, 1995).
The most important treatment goal for type 1 diabetes patients is to maintain
blood glucose levels within the normal range (Peyrot, McMurray, and Kruge, 1999). This
will help facilitate normal growth and development and prevent the development of long
term, negative health complications (Silverstein, 1994; Johnson, 1995). Blood glucose
levels should be maintained in the range of 80-120 m g/100 ml, especially before each
meal and at bedtime. In order to maintain blood glucose levels within this relatively
narrow range, patients frequently monitor their blood glucose levels and administer daily
injections of insulin as needed. Unfortunately, the current method of administering
exogenous insulin only crudely approximates the more accurate functioning of a normal,
healthy pancreas (Johnson, 1995).
To counteract these inaccurate approximations, patients with type 1 diabetes are
strongly encouraged to closely monitor their blood glucose levels on a daily and
consistent basis. Close monitoring is necessary to properly adjust other important
treatment components of the regimen, including insulin dose, type of diet, and quantity of
exercise (Rubin & Peyrot, 2001). Currently, standard recommended guidelines suggest
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that patients should monitor their blood glucose levels four times per day, particularly
before each meal and at bedtime (DCCT, 1994). Checking of blood glucose levels is
accomplished by pricking the finger or another part of the body (i.e., forearm) to obtain a
small sample of blood. The blood sample is then placed on a reagent strip and read by an
electronic device (i.e., blood glucose monitor) that calculates the blood glucose level. The
majority of the monitors in use today also have a built-in memory feature that stores the
date, time, and blood glucose level for each check (Johnson, 1995).
If patients do not adhere to their blood glucose checks, they will be at a higher
risk for developing hyperglycemic (i.e., high blood sugar levels) and hypoglycemic (i.e.,
low blood sugar levels) episodes. Hyperglycemia is a condition in which blood glucose
levels rise above the normal range, while hypoglycemia occurs when levels drop
significantly below the recommended range. Hypoglycemia can be a dangerous and
potentially life-threatening condition. Since many patients fear hypoglycemic episodes,
they may intentionally maintain their blood glucose levels in the above normal range.
Unfortunately, high blood glucose levels over extended periods of time can often result in
a number of diabetes-related complications, including eye and kidney disease (i.e.,
retinopathy), cardiovascular disease, neurological problems, gangrene, and joint mobility
problems (Dormal & LaPorte, 1985; Rubin & Peyrot, 1999; Silverstein, 1994).
The Diabetes Control and Complications Trial (DCCT)
For many years, endocrinologists, who specialize in the treatment of type 1
diabetes, have hypothesized that by maintaining blood glucose levels within or close as
possible to the normal range, many of the diabetes-related complications could be either
delayed, significantly minimized, or even eliminated (Johnson, 1995). A prospective
study called the Diabetes Control and Complications Trial (DCCT) was purposely
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conducted to evaluate this hypothesis (DCCT, 1994). Specifically, this study investigated
the effects of “tight control” (i.e., maintaining blood glucose levels in or close to the
normal range) versus “conventional care” in a group of adolescents’ aged 13 to l7 years
(DCCT, 1994). Adolescent patients were randomly assigned to either the “conventional
care” condition (i.e., one or two daily injections of exogenous insulin and only one daily
check of blood glucose level) or the “intensive therapy” condition. The intensive therapy
condition required participants to administer three or more daily injections of insulin. To
ensure that participants in the intensive therapy condition were obtaining “tighter”
metabolic control, participants were also required to monitor their blood glucose levels at
least four times per day. The positive effects of frequent monitoring of blood glucose
levels were clearly demonstrated in the DCCT study. Adolescent patients assigned to the
“intensive therapy” condition significantly reduced the onset or risk of developing
neurological and other types of macrovascular complications. For example, the intensive
therapy condition reduced the risk of developing retinopathy by 53% (DCCT, 1994).
Defining Treatment Adherence
Researchers have used a variety of different definitions for conceptualizing
“treatment adherence” (La Greca & Schuman, 1995). The majority of investigators have
elected to define treatment adherence as “the extent to which a person’s behavior . . .
coincides with medical or health advice” (Haynes, 1979, pp. 2-3). One particular problem
with this approach to defining adherence is related to the fact that many individuals, even
with the same medical diagnosis (e.g., type 1 diabetes), may be prescribed different
medical regimens (La Greca, 1990; La Greca & Schuman, 1995). In addition, due to the
fact that many medical regimens are complex, this definition may include a number of
different types of adherence behaviors, including taking medications (i.e., pills, daily
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insulin injections), monitoring blood glucose levels, exercising, following prescribed
diets, completing self-monitoring logs, and any other important lifestyle changes required
by the medical regimen. In the present study, we will be focusing on only one individual
treatment component (i.e., blood glucose monitoring) of the diabetes regimen. In terms of
blood glucose monitoring, the DCCT study clearly indicated that patients with type 1
diabetes should be checking their blood glucose levels four times per day. Consequently,
we will define treatment adherence to blood glucose monitoring as the extent to which
the patient’s blood glucose checking behavior coincides with the standard recommended
frequency of 4 checks per day.
Three main strategies have been used to operationalize adherence behavior. The
first strategy involves classifying adherence into different categories. Using a categorical
approach, a patient may be labeled as “adherent” or “nonadherent” by establishing some
type of criterion or cut-off score (Phipps & DeCuit-Whalley, 1990). For example,
patients who remember to take their medications only 50% of the time may be grouped
into the nonadherent category. Second, investigators have taken a more comprehensive
approach that considers all behaviors required in a medical regimen (e.g., taking required
dosage of medications, monitoring blood glucose levels, completing self-monitoring
tasks). By using this approach, an overall index score can be calculated to represent the
patient’s degree of overall compliance with the treatment regimen (Becker, Drachman, &
Krischt, 1972). The third approach, which operationalizes adherence on a continuous
scale, involves calculating adherence rates for specific behaviors required in the medical
regimen (Carney, Schechter, & Davis, 1983; Johnson et al., 1986; Lowe & Lutzker,
1979; Rapoff, Lindsley, & Christophersen, 1984; Rapoff, Purviance, & Lindsley, 1988).
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For example, an investigator may calculate an overall adherence rate by dividing the
number of adherence behaviors (i.e., swallowing medications) completed by the patient
by the number of pills prescribed each week. Using this methodology, separate adherence
rates can be calculated for each of the different components of the medical regimen
(Johnson, 1995). Compared to the other approaches, this latter approach has the distinct
advantage over other methods because of its increased objectivity by individually
monitoring one or more components of the medical regimen. In the proposed study,
adherence to blood glucose monitoring will be operationalized on a continuous scale of
measurement.
Assessment of Treatment Adherence
As many authors point out, one of the more difficult challenges facing pediatric
psychologists who are conducting applied research involves the issue of how to actually
measure treatment adherence (La Greca, 1990a; La Greca & Schuman, 1995). As in all
clinical research, it is extremely important to obtain reliable and valid assessments of
your target behavior. La Greca and Schuman (1995) outlined some of the more
commonly used assessment methods in treatment adherence research, which include drug
assays, patient and parental verbal report, adherence ratings by health care professionals,
pill counts, and electronic monitoring devices (i.e., blood glucose monitors). Many of
these methods have their own distinct advantages and limitations. For example, although
verbal self-reports by the patient are relatively easy to obtain, they are often biased in
socially desirable ways and tend to overestimate the true level of treatment adherence
(Rapoff & Christophersen, 1982).
Rapoff (1999) proposes that there is no “gold standard” for measuring treatment
adherence. However, Rapoff (1999) and Lemanek, Kamps, and Chung (2001) posit that
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assessment of treatment adherence should consist of automated monitoring through
electronic devices (i.e., blood glucose monitors), structured telephone interviews on a
frequent basis, periodic checks by parents to ensure regimen tasks are being completed,
and frequent checks through blood assays to verify that the medications are being
ingested. By and large, blood assays are recognized as being one of the more reliable and
objective methods for quantifying treatment adherence. With type 1 diabetes, a sample of
blood is often taken during the patient’s clinic visit to obtain a laboratory index of
metabolic control (i.e., glycosylated hemoglobin A ic). Research has shown that this is a
more reliable indicator of treatment adherence than verbal reports by the adolescent
patient or their parents. Even when downloaded data is obtained from the blood glucose
monitors, the reliability of the data can be questioned as many youngsters with type 1
diabetes may know how to manipulate the monitors (i.e., test someone else’s blood, use
water on the reagent strip to obtain a better reading).
Interventions for Enhancing Treatment Adherence
Intervention strategies aimed at improving treatment adherence can be generally
categorized into one of the following categories: (1) educational; (2) organizational; and
(3) behavioral (La Greca & Schurman, 1995; Lemanek, 1990; Lemanek, Kamps, &
Chung, 2001; Rapoff & Bamdard, 1990). We will briefly review several studies
conducted in each these categories.
Educational Interventions
A large number of published studies have incorporated educational components
into their intervention designs. The foremost goal of educational approaches is to ensure
that patients’ and families’ know how to carry out the medical regimen effectively (La
Greca & Schuman, 1995). At the time of initial diagnosis education is particularly
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important, even more so with complex medical regimens. Patients and families require
knowledge and skills to recognize disease-related symptoms and complications, to
perform complicated tasks (e.g., administering insulin injections), and to efficiently
organize their schedules around the timing of medications (La Greca & Schuman, 1995;
Lemanek, Kamps, & Chung, 2001). With complex medical regimens, it is even more
crucial for patients to receive some type of educational training. Education components
can be provided through verbal instruction, videos, and other written materials (Lemanek,
Kamps, & Chung, 2001). For example, Gilbert et al. (1982) used an educational film
procedure to teach children aged 6 to 9 years how to perform daily injections of insulin.
The results of this study suggested that older girls obtained higher scores on a measure of
self-injection skills; however, younger girls and boys did not benefit as much from this
procedure (Gilbert et al., 1982).
The overall assumption of educational approaches is that by educating patients
and families about the disease, positive changes in adherence behaviors will follow.
However, many authors argue that interventions that rely solely on educational
approaches are not sufficient in increasing adherence behaviors, especially for complex
medical regimens (La Greca & Schuman, 1995; La Greca & Skyler, 1991). Many
researchers have concluded that education-alone interventions need to be complemented
with additional treatment components, including increased social support, parental
monitoring, family therapy, problem solving, and operant-based reinforcement
procedures (La Greca & Skyler, 1991; La Greca & Schurman, 1995; Lemanek, Kamps, &
Chung, 2001).

12
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Organizational Interventions
Organizational interventions strategies focus on changing specific components of
the medical regimen or the way in which the office-based visits are conducted. For
example, researchers have simplified various components of the diabetes regimen by
providing self-monitoring forms, calendars, pill counters, or schedules for administrating
medications, and other written instructions to follow (Johnson, 1995). In one study
conducted by Anderson, Brackett, Ho, and Lafel (1999), adolescents in a “teamwork
intervention” significantly improved their metabolic control when compared to those
assigned to a “control condition”. The teamwork intervention condition consisted of
written materials emphasizing the importance of family teamwork and strategies for
avoiding parent-adolescent conflicts. This intervention was unique in that it was costeffective and relatively easy to implement in the context of the general medical setting.
Behavioral Interventions
Interventions using behavior modification principles consistently have obtained
the most positive outcomes in improving treatment adherence, especially when only one
component of the medical regimen is targeted (Gross et al., 1985). When more than one
treatment component is targeted, more inconsistent results have been obtained (Anderson
et al., 1989). The majority of these types of interventions have enhanced treatment
adherence by using reinforcement-based contingencies (Johnson, 1995; La Greca &
Schuman, 1995; Lemanek, Kamps, & Chung, 2001). In many of these studies,
researchers used positive reinforcement to increase the frequency of the targeted
adherence behavior. Below, we will review a sample of studies that have achieved
success with reinforcement-based interventions.
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Reinforcement-Based Interventions
Intervention strategies that rely on reinforcement-based principles have had the
most success when only one treatment component (i.e., medication compliance) is
targeted (Rapoff, 1989; Rapoff, Purviance, & Lindsley, 1988). Carney, Schechter, and
Davis (1983) conducted a study in which they applied an intervention consisting of two
main components - parental contingent praise and a token economy program (i.e.,
points). The intervention was designed to increase self-monitoring of blood glucose
levels. Significant improvements in blood glucose monitoring for two of the three
subjects were obtained during intervention and at a 4-month follow-up session. With a
larger sample size, Wysocki et al. (1989) conducted a similar study by offering monetary
rewards to adolescents when they completed their blood glucose checks. Higher rates of
blood glucose monitoring were obtained when the participants received the added
incentives than when compared to those who did not receive such incentives.
Similarly, Rapoff, Purviance, and Lindsley (1988) and Rapoff, Lindsley, and
Christophersen (1984) conducted several studies investigating the effectiveness of
positive reinforcement (i.e., praise by parents) and a token economy program (i.e.,
tokens) in increasing medications and splint wearing compliance among children
diagnosed with juvenile rheumatoid arthritis (JRA). The investigators of these studies
indicated that behavioral strategies were quite effective in improving medication
compliance. A large number of published studies have documented improved adherence
to a variety of regimen tasks, including following dietary guidelines, exercising, weight
reduction, and appointment keeping (Finney, Lemanek, Brophy, & Cataldo, 1990;
Greenan-Fowler, Powell, & Vami, 1987; Da Costa, Rapoff, Lemanek, & Goldstein,
1997; Killam, Apodaza, Manella, & Vami, 1983; Magrab & Papadopoulou, 1977).
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Behavioral Family Systems Therapy (BFST)
In another line of research, Wysocki et al. (2001a; 2001b; 2000; 1995) have
investigated the effectiveness of Behavioral Family Systems Therapy (BFST). During the
adolescent years, health care professionals and parents often hold expectations that
adolescents will begin to take greater individual responsibility for managing their medical
condition (Anderson et al., 1990; Wysocki et al., 1992). The adolescent years are
characterized by an increased push for independence; consequently, this time period may
result in increased levels of parent-adolescent conflict (Arnett, 1999). In both crosssectional and prospective research, higher rates of parent-adolescent conflict have been
found to be significantly associated with poorer treatment adherence and metabolic
control, and an increased risk for developing many diabetes complications (Bobrow,
AvRuskin, & Siller, 1985; Gustafsson, Cederblad, Ludvigsson, & Lundin, 1987; Hauser,
Jacobson, Lavori, Wolfsdorf, Herskowitz, Milley, & Wertlieb, 1990; Koski, Ahlas, &
Kumento, 1976; Lorenz & Wysocki, 1991; Miller-Johnson, Emery, Marvin, Clarke,
Lovinger, & Martin, 1994; Wysocki, 1993).
Using BFST, Wysocki and colleagues attempted to reduce the level of parentadolescent conflicts within the family system. These investigators hypothesized that an
intervention strategy designed to reduce the level of parent-adolescent conflict within the
family system may improve treatment adherence to the diabetes regimen. BFST consists
of four treatment components: (a) problem-solving training; (b) communication skills
training; (c) cognitive restructuring; and (d) functional and structural family therapy
(Wysocki et al., 2001). Results of this research suggest that BFST is quite effective in
improving the quality of parent-adolescent relationships among adolescents with type 1
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diabetes. Furthermore, increased treatment adherence rates were evident for many
participants at follow-up sessions (Wysocki et al., 2001; Wysocki et al., 2000).
Antecedent Prompting Interventions
Although the studies reviewed above have clearly documented the efficacy of
behavioral strategies, one disadvantage is the relatively high level of physician, patient,
and parental involvement that is required to implement the interventions. Such laborintensive procedures may not be the most efficient and cost-effective strategies to use in
the context of real-world medical settings. Another effective behavioral strategy that has
not been widely applied in pediatric settings is the use of antecedent prompting
procedures. Antecedent prompting generally involves providing patients with a visual cue
(e.g., written or verbal reminder) or other type of prompt to remind the patient to
complete a specific management task. A prompt is a supplemental stimulus that increases
the probability of performing the appropriate response (Touchette & Howard, 1984).
Few studies to date have examined the effectiveness of antecedent prompting
procedures in improving treatment adherence to prescribed medical regimens. In one of
the few studies on treatment adherence that has used antecedent prompting procedures,
Lowe and Lutzker (1979) used a written memo (i.e., written prompt) to increase
adherence to urine testing, foot care, and dietary-related tasks in a 9 year-old girl
diagnosed with type 1 diabetes. The written memo (i.e., prompt) was posted in easy-tofind locations, including the kitchen and bathroom. The memo contained a list of “selfcare tasks” that needed to be completed on a daily basis. If the subject engaged in
noncompliant behavior, the subject’s mother would provide a verbal prompt to complete
the required task (Lowe & Lutzker, 1979). Significant improvements were found in the
girl’s adherence to dietary-related tasks. No significant effects were evident in her
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adherence to urine testing or foot-care (Lowe & Lutzker, 1979). However, after
implementing a token economy program, the girl’s adherence rates in these other areas
improved significantly (Lowe & Lutzker, 1979).
Wong, Seroka, and Ogisi (2000) used a written checklist prompt in a memoryimpaired patient with type 1 diabetes to increase adherence to the blood glucose
monitoring component of the medical regimen. The written checklist consisted of visual
stimuli designed to improve performance to blood glucose monitoring. Results of this
study showed that an inexpensive and portable written checklist prompt could be used to
increase adherence to an individual treatment component in a patient with diabetes and
severe memory impairment.
In a more recent study, Berlant (2004) investigated the effects of two different
types of behavioral prompts on the level of treatment adherence to the exercise
component of the diabetes regimen. The two behavioral prompts were delivered on a bi
weekly basis through telephone contacts. Participants were randomly assigned to one of
two conditions. One group received “motivational enhancement prompts”, while the
other group received “standard behavioral prompts.” Results from this study indicated
improvements in the exercise level for both the standard behavioral and the motivational
enhancement prompt; however, greater levels of behavioral change were found with the
motivational enhancement prompt. The results of this study suggest that an antecedent
prompt delivered through bi-weekly telephone calls can be effective in enhancing
treatment adherence to the exercise component of the diabetes regimen.
Antecedent prompting procedures have also been used more widely in other areas
of research. For example, antecedent prompting procedures have been found to be
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effective in improving various self-management tasks among children with severe
intellectual disabilities (Lancioni, O ’Reilly, & Campodonico, 2002; McClannahan &
Krantz, 1997; Taylor & Levin, 1998). Lancioni, O ’Reilly, and Campodonico (2002)
investigated the efficacy of a verbal prompt with an individual diagnosed with multiple
disabilities. In this study, the investigator used verbal prompts to significantly increase
the individual’s performance in various self-help tasks (i.e., dressing, turning on the water
tap, washing hands, brushing teeth, etc.). The verbal prompts were also automatically
delivered through portable paging technology. The results of this study suggest that the
paging intervention was effective in improving the individual’s performance in
completing various self-help tasks.
Other researchers have also used antecedent prompting strategies to increase
social interactions in children diagnosed with autism and other developmental disorders.
Investigators presented either textual or tactile prompts to increase the frequency of
verbal initiations (Krantz & McClannahan, 1998; McClannahan & Krantz, 1997; Taylor
& Levin, 1998, Shabani, Katz, Wilder, and Beauchamp, 2002). The prompts used in these
studies consisted of printed words and/or pictures on index cards. The tactile prompts,
which were delivered through portable paging technology, were in the form of a beeper
sound and/or vibration. A remote control device activated the tactile prompts. Shabani et
al (2002) and Taylor and Levin (1998) concluded that tactile prompts are an effective
strategy for increasing verbal initiations in children with developmental disabilities.
Antecedent prompting procedures have also been applied in other settings to
increase various safety-related behaviors in adults. For example, Austin, Alvero, and
Olson (1998) conducted a study investigating the effectiveness of a verbal prompt in
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increasing safety belt use among patrons at a local restaurant. As patrons of the restaurant
exited the restaurant, hostesses provided a verbal prompt by stating, “Don’t forget to
buckle up” (Austin, Alvero, & Olson, 1998). The prompting intervention increased safety
belt use from 57% at baseline to 77% during the intervention condition (i.e., prompting
conditions). The results of this study clearly demonstrate the effectiveness of a verbal
prompt in increasing safety-related behavior. Other researchers in this area have also
obtained similar results with verbal prompts (Engerman, Austin, & Bailey, 1997; Geller,
Johnson, & Pellton, 1982). The authors of these studies note that verbal prompts are
particularly appealing, as they have been shown to be a cost-effective method for
improving safety-related behaviors.
Antecedent prompting procedures may have several advantages over other
reinforcement-based interventions. First, they rely less on extensive physician, patient,
and parental involvement. Second, antecedent prompting strategies may be more costeffective and less time consuming, especially if the prompts are delivered through
automated paging technology.
Antecedent prompting procedures also encourage patients to take more
responsibility in the management of their disease. With adolescent populations, taking
increasing responsibility in managing their diabetes regimen may be particularly crucial.
As children get older, parents and health care professionals may develop higher
expectations for the young adolescent to assume greater independence in carrying out
diabetes-related tasks. When such tasks are not adhered to satisfactorily, greater levels of
parent-adolescent conflict may ensue (Wysocki et al., 2001). Research has consistently
revealed that higher levels of parent-adolescent conflict are significantly associated with
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poorer treatment adherence among adolescent patients with type 1 diabetes (Bobrow,
AvRuskin, & Siller, 1985; Davis et al., 2001; Gustafsson, Cederblad, Ludvigsson, &
Lundin, 1987; Hauser et al., 1990; Kosi, Ahlas, & Kumento, 1976; Lorenz & Wysocki,
1991; Miller-Johnson, Emery, Marvin, Clarke, Lovinger, & Martin, 1994; Wysocki,
2000a; 2000b; 2001).
It is reasonable to hypothesize that an intervention that relies less on parental
involvement may potentially reduce the level of parent-adolescent conflict, which may
potentially enhance treatment adherence among adolescent patients with type 1 diabetes.
As Wysocki and colleagues have demonstrated, reducing the level of parent-adolescent
conflict has the potential to enhance treatment adherence at follow-up sessions (Wysocki
et al, 2001). Therefore, as La Greca and Schuman (1995) suggest, antecedent prompting
procedures (i.e., visual cues, written reminders) may be particularly appropriate in cases
where family members are attempting to increase the adolescent’s involvement in the
medical regimen. Furthermore, prompting procedures may allow for more effective
transfer of stimulus control to stimuli in the adolescent’s natural environment. That is,
prompting procedures may effectively increase adolescent’s adherence during times
when they cannot be closely monitored (i.e., when they are away from home). Use of
automated paging technology may also be a particularly useful way of delivering prompts
in these situations.
Limitations of Previous Research
Although some of the studies reviewed above used single-subject research
designs, the majority of the published studies on treatment adherence have used largescale correlation designs (Howard, Moras, Brill, Martinovich, & Lutz, 1996; Lemanek,
Kamps, & Chung, 2001). Many of these studies have utilized inconsistent assessment
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measures, treatment protocols, and research designs, which limit the utility of the
research findings (Lemanek, Kamps, & Chung, 2001). Lemanek, Kamps, & Chung
(2001) also point out that previous research on treatment adherence has focused more on
identifying behavioral correlates of treatment nonadherence with little emphasis on the
actual process of designing effective intervention strategies to modify the behavior of
interest. In addition, in many of the studies reviewed above, investigators combined
multiple treatment components (i.e., education, praise, token economy programs) to
improve treatment adherence. As a result, it is difficult to determine what specific
components of the intervention package are effective (La Greca & Schuman, 1995). The
present study used a series of single-subject research designs to redress some of these
deficiencies by allowing us to more specifically address the effectiveness of an
antecedent prompting intervention specifically. It will also facilitate a more in-depth
examination of the treatment progress for each individual participant. Since this
intervention approach used in this study is novel, a single-subject research design
approach also allowed us to pay closer attention to what modifications would be needed
to successfully implement the intervention in a real-world medical setting.
Statement of Purpose
This study evaluated the impact of a behavioral procedure on treatment adherence
in young individuals diagnosed with type 1 diabetes who demonstrated poor treatment
adherence to the blood glucose monitoring component of the medical regimen. By using
automated paging technology, antecedent prompts were delivered to encourage and
promote increased blood glucose checking. An antecedent prompting procedure was
selected as the intervention strategy for several reasons. We believe that many parents
forget to provide verbal prompts or the teenagers themselves forget to complete their
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blood glucose checks, perhaps due to a busy school, work, family, or social schedule
(Rapoff, 1999). The antecedent prompting procedure was selected as it may be an
effective way to remind adolescents to check their blood glucose levels when away from
home. A portable and automated intervention strategy also seemed to be a feasible
treatment option for promoting increased independence to the medical regimen. In light
of the managed health-care environment, the behavioral approach used in this study was
also seen as advantageous because the intervention would be time-efficient and relatively
easy to implement in the context of the general medical setting.
There were several aims of this study. A primary aim of this study was to test the
feasibility of implementing an antecedent prompting procedure (i.e., prompts) delivered
through automated paging technology in the context of a real-world medical setting. A
second aim was to identify whether or not patients would be interested in an innovative
intervention designed to improve blood glucose monitoring. As with all studies, another
objective was to identify what modifications would be needed in the research design and
intervention to successfully implement the intervention with this population. And finally,
this study was interested in obtaining preliminary data on the effects of the intervention
for improving blood glucose monitoring and health outcomes. As this was a study
investigating the use of an innovative intervention approach in a real-world medical
setting, more detailed information on the practical application of the intervention will be
provided as needed.
Method
Participants
Six participants were recruited from an endocrinology clinic located in a tertiary
medical center, situated in a relatively large Midwestern city. By using standard clinic-
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based procedures, board-certified endocrinologists completed medical chart reviews and
informal evaluations to determine eligibility. Patients and families were provided with a
recruitment script and informational flyer inviting them to contact the student investigator
by phone (see Appendix A; Page 74). Upon being contacted by the family, the student
investigator provided additional information about the study and scheduled an officebased visit (see Appendix B; Page 78). To be eligible for the study, the patients had to
meet all of the following criteria: (a) diagnosis of type 1 diabetes for at least one year; (b)
at least be 12-years-old; (c) at least one annual office visit to the endocrine clinic during
the past year; (d) no diagnosis of any other serious medical conditions; and (e) no newly
diagnosed or severe psychiatric conditions (i.e., cognitive impairment). Patients also had
to demonstrate an average adherence rate of 50% or less over a 3-month period.
Adherence rates were calculated by dividing the total number of blood glucose checks
completed by the number of checks prescribed for a 3-month period and multiplying by
100%. We recruited only those patients with extremely low adherence rates to the blood
glucose monitoring component of the diabetes regimen because we wanted to evaluate
whether or not the intervention would produce positive treatment outcomes for a
difficult-to-treat population (i.e., extremely poor treatment adherence). If positive
treatment outcomes were found within this population, it was believed that the
intervention may be effective for patients with higher treatment adherence rates as well.
The minimum age requirement was selected for several reasons. First, adolescents
12-years-old or older are often encouraged to take increased individual responsibility in
the management of the diabetes regimen. As adolescents achieve more independence
from their families, health care professionals will have greater expectations for them to
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successfully adhere to all treatment components of the medical regimen (Anderson,
Auslander, Jung, Miller, & Santiago, 1990). Second, we recruited adolescents because
the extant literature has consistently shown that higher levels of parent-adolescent
conflict are often associated with lower treatment adherence rates and poorer metabolic
control (Anderson, Brackett, Ho, & Laffel, 1999). A third reason for selecting
adolescents was to ensure that they had the requisite skills to properly operate the
electronic pagers in a responsible manner.
Equipment
Each participant received a Motorola™ alphanumeric pager with numeric and text
messaging capability. Each pager had a specific pager number, internet email address,
and a quarterly service contract with statewide and national coverage plans. Statewide
and national coverage plans were selected in the event that participants traveled far away
from home on vacations or school trips. The service plan also consisted of an unlimited
number of numeric and/or text pages per month. A software program (PageMaster™)
was installed on a Dell™ desktop computer, which functioned by automatically paging
the participants at pre-determined times through a standard computer modem. The
PageMaster™ software program was set-up to automatically dial-up the participant’s
pager number and deliver a prompt (i.e., “Megan. It is 8:00 AM. It is time to check your
blood sugar level”).
Measures
Blood Glucose Monitoring. The primary dependent measure was the total number
of blood glucose checks performed each week. Treatment adherence to blood glucose
monitoring was assessed with a blood glucose monitor (i.e., meter), an electronic device
that records and stores the exact date, time, and blood glucose level of each check. In
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order to minimize the research demands and increase the overall convenience for
families, clinic visits and home-based visits were not completed to download the monitor
data. Rather, participants verbally reported the number of blood glucose checks
performed during scheduled telephone contacts with the student investigator. While
talking with the investigator on the phone, participants reviewed and verbally reported
the stored data by viewing a digital display on their monitors. The exact time, date, and
blood glucose level of each check was collected to evaluate the timing of the blood
glucose checks and to assess for changes in metabolic control over time. To encourage
accurate and honest reporting, participants were required to have the monitor in-hand
during the telephone contacts and to precisely report the exact date, time, and blood
glucose level of each check. Participants were also told that medical chart reviews would
be completed to cross-check for accuracy of verbal reporting. Although parent self-report
of the monitor data may have reduced the risk of socially biased responding, this option
was not selected since this study was specifically interested in promoting increased
adherence among adolescents.
Demographic Questionnaire. Demographic questionnaires were completed at
study enrollment to collect personal information on the families, largely for descriptive
purposes. Participants and their respective parent(s) reported standard demographic
information, including age, gender, ethnicity, employment status, and educational level.
Specific information was also obtained on the parent-adolescent relationship, the
adherence level to other treatment components of the diabetes regimen, the presence of
conflicts surrounding the medical regimen, the situations in which blood glucose

25

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

monitoring was less likely to be completed, and whether or not parental verbal reminders
were used to prompt the completion of the diabetes-related tasks.
Teen Adjustment to Diabetes Scale (TADS; Wysocki, 1993). While the primary
goal of this study was to evaluate the impact of the intervention on blood glucose
monitoring, additional measures were used to gather qualitative data on other ancillary
behaviors that may had been impacted by the intervention. The TADS is a 21-item
Likert-type scale that yields scores on both the parent’s and adolescent’s adjustment over
the past 3-months in the following areas: Behavioral, Affective, and Attitudinal
(Wysocki, 1993). The TADS was selected to gather pilot data to evaluate the potential
effects of the intervention on other diabetes-related behaviors and attitudes. Higher total
scores on the TADS indicate better overall adjustment to the diabetes regimen over the
past 3 months. This measure has been evaluated on more than 600 participants and has
been shown to have good internal consistency (alpha = .88 for adolescents; alpha = .91
for mothers; alpha = .84 for fathers; Wysocki et al., 2001).
Self-Care Inventory (SCI; Greco et al., 1990).The SCI is a 14-item instrument
designed to assess adolescents’ level of treatment adherence to the diabetes regimen for
the past 3 months. The SCI has been demonstrated to significantly correlate with
hemoglobin A ic values, an objective laboratory measure of metabolic control. Higher
scores on the SCI indicate better overall treatment adherence to the medical regimen. The
SCI has both a parent and adolescent form. The SCI has demonstrated internal
consistency (Greco et al., 1990). The SCI was used to assess for intervention effects not
only on blood glucose monitoring, but to other components of the medical regimen,
including diet, exercise and insulin injections.
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Diabetes Responsibility and Conflict Scale (PRC; Rubin, Young-Hyman, &
Peyrot, 1989).Because higher rates of parent-adolescent conflict have been found
to be significantly associated with poorer treatment adherence and metabolic control, and
an increased risk for developing negative health complications, the DRC was used to
determine if the intervention had an ancillary impact on the level of parent-adolescent
conflict. The DRC consists of items designed to assess the degree of conflict over 15
diabetes-related tasks. Higher scores on the DRC indicate greater levels of parentadolescent conflict surrounding the diabetes regimen. The DRC has demonstrated high
internal consistency (alpha = .92 for adolescents; alpha = .86 for mothers; alpha = .89 for
fathers; Wysocki et al., 2001).
Medical Chart Reviews. Medical chart reviews as well as contact with pertinent
health care professionals were used to obtain data on age of diagnosis, hemoglobin A ic
values, and number of emergency room visits and hospitalizations in the previous year.
Metabolic control was measured by hemoglobin A ic values, an indirect and retrospective
objective laboratory measure of average blood glucose levels over the previous 2- to 3months. Higher A ic values indicate higher blood glucose levels, thus indicating poorer
metabolic control. Medical chart reviews were also used to collect available follow-up
data on the frequency of blood glucose checking, appointment keeping in the endocrine
clinic, and the number of hospitalizations or emergency room visits since study
participation.
Procedure
Meter (Pre-Baseline). At a pre-baseline session, informed consent to participate in
the study was obtained during a brief office-based visit, which ranged in time from 45 to

27

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

60 minutes (see appendix D; Page 97). Adolescents and their respective parent(s) were
asked to complete the demographic and self-report study questionnaires. Specific
instructional support was then provided about the telephone contact procedures,
intervention (i.e., prompts delivered through automated paging technology), and the
operation and rules of the alphanumeric electronic pagers (see appendix E; Page 110). An
operation manual containing detailed instructions on the available pager features were
provided to the participants. Brief practice sessions were also conducted to familiarize the
participants with the operation of the pager and to ensure that they clearly understood
how to properly operate the pager in a responsible and safe manner. Behavioral rehearsal
was used to verify that the participants could correctly report the exact date, time, and
blood glucose level of each check by viewing the built-in digital display on their blood
glucose monitors. Participants were informed that the investigator would complete
telephone contacts every 3-days at agreed-upon dates and times. Participants also
identified times at which they usually eat breakfast, lunch, and dinner, and when they
typically go to bed each night. Participants were asked to record four convenient times to
receive the prompts designed to remind them to complete the recommended number (i.e.,
4 checks) of blood glucose checks per day. Before leaving, each participant was provided
with a Motorola™ alphanumeric pager.
Telephone contacts were conducted every three days to collect baseline data on
the frequency of blood glucose monitoring (see appendix F; Page 115). The exact date,
time, and blood glucose level of each check was recorded on a data collection form (see
appendix G; Page 117). Qualitative data on the number of days that the participants’
reportedly adhered to other diabetes-related tasks (i.e., diet, exercise, insulin injections)
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were recorded on a second data collection form (see Appendix G; Page 117). In order to
facilitate consistent telephone contacts, an effort was made to contact the participants at
convenient times. When unforeseen circumstances impacted the availability of the
participants, several attempts were made to contact the participants at agreed-upon times.
If participants refused to complete the telephone contacts or could not be reached for an
extended period of time, participants were officially dropped from the study, with the
exception of family emergencies or extended vacations.
Baseline. During the baseline phase, participants did not receive any prompts (i.e.,
pages) nor did they have access to the free paging service. No attempt was made during
baseline to improve blood glucose monitoring. Participants were contacted by telephone
every 3-days to determine the total number of blood glucose checks performed each day.
A probe assessment approach (i.e., every 3 days) was selected because it has been shown
to approximate data collected on a more continuous basis (Bijou, Peterson, Harris, Allen,
& Johnson, 1969). In addition, it was believed that probe assessments would significantly
reduce the potential risk of participant reactivity impacting blood glucose monitoring
during the baseline phase (Kazdin, 1982). Baseline data were graphed and continually
monitored, and visual inspection was used to assess for stability, trend, and variability in
the data. If baseline data declined by more than 20% (i.e., downward trend), the
intervention was immediately implemented. A decreasing trend was determined on an
individual basis, taking into consideration the participant’s initial adherence rate in the 2weeks prior to study entry.
Intervention. After baseline, participants were contacted by telephone and
informed by the student investigator that their alphanumeric pager had been activated and
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that they would start receiving prompts (i.e., pages) the following day. While on the
phone with the investigator, a confirmation prompt was sent to the participant to confirm
that the electronic pager was functioning properly. The main goal of the intervention (i.e.,
antecedent prompting procedure) was to provide antecedent prompts in the form of text
messages (i.e., “Megan. It is 8:00 AM. It is time to check your blood glucose level”) to
remind participants to perform the recommended 4 blood glucose checks per day. The 4
prompts were sent at the predetermined times identified during the office-based visit. The
times of the prompts were selected to closely approximate the times in which the
participants typically ate their meals (i.e., breakfast, lunch, dinner) and went to bed each
night. Standard medical guidelines indicate that these are the most ideal times to perform
blood glucose monitoring. It was also anticipated that these paging times would not
significantly interfere with the participant’s academic functioning in school. Participants
were asked to carry the pager with them at all times, even when away from home or at
school. In order to increase treatment integrity, each participant was provided with a
specific pager number and encouraged to freely use the pager service with their family
and friends. During school hours, participants were instructed to set the silent mode
feature and to not abuse or misuse the paging service. Although many school districts
allow the use of electronic devices in school settings for medical reasons, an official letter
was provided to each participant in the event that school officials questioned the use of
the pager (see appendix H; Page 118).
During the intervention phase, participants were sent four prompts at pre
determined times. For example, one participant in this study chose to be paged at the
following times: (a) 7:30 AM; (b) 12:00 PM; (c) 5:00 PM; and (d) 9:00 PM. Telephone
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contacts were completed once per week to collect intervention data on the total number of
blood glucose checks performed each week. As in the baseline phase, the exact time,
date, and blood glucose level of each check were collected from the participants. For this
study, a positive treatment outcome was defined as a 30% or more increase in the
frequency of blood glucose monitoring from the baseline to the intervention phase. The
intervention remained in effect for each participant for several weeks, unless a significant
negative trend was found in the data, at which time the participant was officially dropped
from the study and referred back to the endocrinologist(s) for additional treatment
options. If visual inspection indicated a significant treatment outcome, the intervention
was gradually withdrawn through the use of a 3-week prompt fading procedure. During
prompt fading, prompts were sent on a random basis based upon the predetermined times.
A block-randomization procedure was used to randomize the test prompt times because it
was expected that random prompts would be less resistance to extinction. The fading
procedure consisted of 3 prompts per day for the first week, 2 prompts per day during the
second week, and 1 prompt per day during the final week. After completing the
intervention phase, participants returned to the baseline phase. Medical chart reviews
were used to collect available 3- and 6-month follow-up data on blood glucose
monitoring.
Experimental Design
A series of single-subject designs (ABAB; AB) were used to evaluate the effects
of the prompts (i.e., antecedent prompting procedure) on blood glucose monitoring and
blood glucose levels. Initially, a multiple baseline across-participants design was planned
for use in this study, but was discontinued due to ceiling effects obtained during baseline.
The total number of blood glucose checks performed in the 2-weeks before study entry
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was also collected and graphed to establish a pre-baseline meter condition. Although 3and 6-month follow-up reviews were planned to collect post-intervention data, medical
chart reviews did not reveal any long-term follow-up data on blood glucose monitoring.
However, follow-up hemoglobin A jc values for several participants were obtained by
medical chart review to assess for changes in metabolic control.
Results
Participant 1
Megan was a 14-year-old girl diagnosed with type 1 diabetes for approximately 5
years. Megan did not have any hospitalizations over the past year. She had relatively
stable, high hemoglobin A ic values in the 2 years before study enrollment, ranging from
8.5 % to 11.2 %. Her pre-study A ic value of 11.2 % indicated an average blood glucose
level of approximately 320 mg/dl in the 2- to 3-months before study enrollment. Megan
obtained a baseline DRC total score of 60 (score range of 14 to 70), indicating a high
level of parent-adolescent conflict surrounding the diabetes regimen. Her mother
obtained a baseline DRC total score of 24, indicating a substantially lower reported level
of parent-adolescent conflict. M egan’s total scores on the SCI (score range of 14 to 70)
and TADS (score range of 21 to 105) were 46 and 76, respectively. Total scores on the
SCI and TADS for her mother were 44 and 70. Collectively, SCI and TADS results
indicated less-than-ideal overall adjustment to and adherence to the medical regimen.
Megan acknowledged that she sometimes purposely did not perform her blood glucose
checks when angry at her parent(s) and during times of high levels of parent-adolescent
conflict. Megan most often forgot to perform her blood glucose checks when at school,
before meals, and occasionally at bedtime. Megan and her mother also reported that
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verbal prompts were frequently used to prompt the completion of various diabetes-related
tasks, including blood glucose checks and insulin injections.
Figure 1 shows M egan’s weekly percentage adherence to blood glucose checks
across meter, baseline, intervention, prompt fading, and return to baseline phases (see
Appendix I; Page 123). During the meter phase, blood glucose checking was 28% and
21% of the recommended frequency (i.e., 4 checks per day or 28 checks per week) in the
two weeks preceding study enrollment. During baseline, blood glucose monitoring
increased to a high of 93% before the actual implementation of the paging intervention,
which indicates a percentage improvement of 357%. Throughout the baseline condition,
Megan repeatedly asked when her pager would be activated and explained that she was
looking forward to using the free paging service with her family and friends. Since
performance remained stable, even after a prolonged baseline, the paging intervention
was implemented. During intervention, blood glucose checking increased by 4%
(percentage improvement of 4%) and remained stable at nearly 100% for the first two
weeks. Performance decreased from 93% to 79% (percentage decrease of 18%) during
prompt fading, but increased slightly and remained relatively stable at approximately
82% (percentage increase of 4%) after return to baseline. Medical chart review revealed
no follow-up data on blood glucose monitoring, due to Megan not bringing-in her blood
glucose meter for a scheduled clinic visit.
Because of the ceiling effect found during baseline, the times of Megan’s blood
glucose checks were also examined in order to determine if the prompts had any impact
on the timing of her checks. In order to determine if Megan became more regular in the
timing of her checks, the number of blood glucose checks that fell within a defined target
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range (i.e., check successfully completed within 15 minutes of the designated time) were
calculated across the baseline and intervention phases. Results showed a modest increase
in the timing of her blood glucose checks from baseline to the intervention phase. During
baseline, 33% of her checks fell within the target range; during the intervention phase,
43% of her checks fell within the target range, indicating a 10% improvement in the
timing of her checks.
Figure 3 shows the results of M egan’s mean 7-day blood glucose levels across
meter, baseline, intervention, and return to baseline. The horizontal line represents
Megan’s average blood glucose level (Aic value of 11.2% = 320 mg/dl) for the 2- to 3months prior to study entry. Examination of M egan’s mean 7-day blood glucose readings
shows substantial improvement in metabolic control. Mean 7-day blood glucose dropped
from a high of 268 mg/ml to 168 mg/ml at the end of baseline, and to a low of 150 mg/ml
at the start of the intervention. Mean 7-day blood glucose increased and then remained
relatively stable at roughly 210 mg/ml. Following return to baseline, mean 7-day blood
glucose was more variable, ranging from a low of 195 mg/ml to a high of 277 mg/ml. All
of Megan’s mean 7-day blood glucose values across experimental conditions were
considerably below the approximate 320 mg/dl level that she maintained in the 2- to 3months before study entry. Changes in A ic values from study entry to follow-up were
also examined. For Megan, Aic values decreased from 11.2 % at study entry to 9.6 % at
intervention completion. At a 4-month follow-up clinic visit, Megan’s Aic value
remained stable at 9.7 %.
Follow-up questionnaire data were also obtained from Megan and her mother. For
Megan, there was a 4-point increase on both the SCI and TADS, indicating a negligible
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change in her overall adjustment and level of treatment adherence to the diabetes
regimen. A 7-point drop was obtained on the parent version of the SCI, indicating a slight
decline in M egan’s overall level of treatment adherence as rated by her mother. In
contrast, a 35-point drop was found in M egan’s DRC score from pre- to post-intervention
indicating that Megan was reporting a significant reduction in the level of parentadolescent conflict surrounding the diabetes regimen.
Participant 2
Sara was a 16-year-old girl diagnosed with type 1 diabetes for approximately 13
years. Medical chart review indicated that she did not have any emergency room visits or
hospitalizations over the past year. She had stable, relatively high hemoglobin A ic values
in the 2 years prior to study entry, ranging from 10% to 11.1%. Her pre-study A ic value
of 9.0% indicated an average blood glucose level of approximately 240 mg/dl in the 2- to
3-months before study enrollment. Sara had a baseline DRC total score of 20 (score range
of 14 to 70), indicating a mild level of parent-adolescent conflict surrounding the diabetes
regimen. In contrast, her mother had a baseline DRC total score of 56, suggesting that
Sara’s mother noted more significant problems with parent-adolescent conflict. Sara’s
total score on the SCI (score range of 14 to 70) and TADS (score range of 21 to 105)
were 30 and 53, respectively. Total scores on the SCI and TADS for her mother were 44
and 69. Ratings on the SCI and TADS revealed less-than-ideal overall adjustment to and
adherence to the medical regimen. Sara admitted that she sometimes deliberately did not
check her blood glucose levels when mad or angry with her mother. Identified times or
circumstances in which Sara most often forgot to perform her blood glucose checks
included the following: at school; before breakfast; before dinner; when she felt fine;
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when she forgot her diabetes supplies; when feeling sick; while hanging out with friends;
and when she did not want to know her blood glucose level. Sara and her mother also
indicated that verbal prompts were often provided to prompt blood glucose checking. The
following written statement was also obtained from Sara: “I get irritated when they
remind me to do my checks all of the time.” Sara’s mother also noted that she had
recently stopped providing verbal reminders due to Sara becoming too upset and anxious.
Figure 1 shows Sara’s weekly percentage adherence to blood glucose checks
across meter, baseline, and intervention phases. Data obtained from Sara’s blood glucose
meter indicated that she was performing 11% to 14% of the recommended frequency in
the 2-weeks prior to study enrollment. During baseline, performance increased to 25% of
the recommended frequency, indicating a percentage improvement of 79% to 127% over
pre-baseline levels. Implementation of the paging intervention increased blood glucose
monitoring to 54% and 61% of the recommended frequency for the first two weeks of the
intervention, indicating a percentage improvement of 116% to 144% over her baseline
performance. A rapid decline to a low of 7% of the recommended frequency (percentage
decline of 771%) was observed during the third and fourth week of the intervention, but
performance increased to nearly 39% (percentage increase of 457%) for the two weeks
prior to study withdrawal. The number of blood glucose checks that fell within the
defined target range (i.e., check successfully completed within 15 minutes of the
designated time) was also calculated across the baseline and intervention phases. During
baseline, 14% of her checks fell within the target range; during the intervention phase,
24% of her checks fell within the target range, indicating a 10% improvement in the
timing of her checks.
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Sara’s mean 7-day blood glucose readings across baseline and intervention
conditions are shown in Figure 3. The horizontal line represents Sara’s average blood
glucose level (Aic value of 9.0% = 240 mg/dl) in the 2- to 3-months preceding study
entry. Mean 7-day blood glucose was at 175 mg/ml at baseline, increased to a high of
295 mg/ml during the second week of the intervention phase, and decreased to a low of
186 mg/dl at the fourth week of the intervention. At study withdrawal, mean 7-day blood
glucose was at 222 mg/dl. Although Sara did not demonstrate improved metabolic
control, four of her mean 7-day blood glucose values were below the approximate 240
mg/ml level (based on her pre-study A ic value of 9.0%) that she maintained in the 2- to 3months before study enrollment.
Return to baseline data were not available for comparison due to Sara dropping
out of the study during the intervention phase. Medical chart review also indicated that
she had not followed through with a clinic visit in the following 12-months after study
drop out. Consequently, no follow-up A ic values were available on Sara for comparison.
Identified reasons for withdrawing from the study included time constraints and the
inconvenience of the frequent telephone contacts and prompts.
Participant 3
Debra was a 15-year-old girl diagnosed with type 1 diabetes for approximately 3
years. Since the time of diagnosis, Debra had a total of 7 hospitalizations. She had stable,
relatively high hemoglobin Aic values in the 2 years prior to study entry, ranging from
12.4 % to greater than 14.0 %. Her pre-study Aic value of 13.5 % indicated an average
blood glucose level of greater than 380 mg/dl in the 2- to 3-months before study
enrollment. Debra had a baseline DRC total score of 21 (score range of 14 to 70),
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indicating a mild level of parent-adolescent conflict surrounding the diabetes regimen. In
contrast, her mother obtained a baseline DRC total score of 57, indicating a higher level
of parent-adolescent conflict reported by the mother. Debra’s total scores on the SCI
(score range of 14 to 70) and TADS (score range of 21 to 105) were 31 and 55,
respectively. Total scores on the SCI and TADS for her mother were 42 and 61,
respectively. Self-report ratings by Debra and her mother revealed less-than-ideal overall
adjustment and adherence to the medical regimen. Debra admitted that she had frequent
conflicts with her parent(s) about checking her blood glucose levels and she sometimes
intentionally did not complete her checks when she was angry with her parent(s).
Identified times or circumstances in which Debra most often forgot to perform her blood
glucose checks included the following: before bedtime and meals; while hanging out
with friends; during the summer months; and when on a vacation or weekend trip. Debra
and her mother indicated that parental reminders were often provided to prompt Debra to
complete her blood glucose checks. Debra also acknowledged that she became angry
with her parent(s) when she was reminded to complete various diabetes-related tasks,
including her blood glucose checks.
Figure 1 shows Debra’s weekly percentage adherence to blood glucose checks
across meter and baseline phases. Results showed a positive trend in performance in the
2-weeks before study entry. During baseline, performance remained stable at nearly
100% for 1 week. Debra was dropped from the study after repeated efforts to contact her
by telephone were unsuccessful. Although limited data was collected, results showed a
rapid increase in performance immediately preceding study enrollment. At study entry,
Debra obtained an A ic hemoglobin value of 13.5 %. Medical chart reviews completed at
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3- and 6-months following participation in this study showed Aic values of 12.6 % and
14.0 %, respectively. Results indicate a 0.9 % decrease in her A ]c value at 3-months, and
a 0.5 % increase at 6-months when compared to her pre-study Aic value of 13.5%.
Medical chart review did not reveal any follow-up data on frequency of blood glucose
monitoring. Medical chart review did not indicate any hospitalizations during study
enrollment or follow-up.
Participant 4
Robert was an 18-year-old male diagnosed with type 1 diabetes for approximately
3 years. Since the time of diagnosis, Robert had a total of 4 emergency room visits and
hospitalizations. He had fairly stable, high hemoglobin Aic values in the 2 years prior to
study entry, ranging from 11.8 % to 13.9 %. His pre-study A ic value of 12.8 % indicated
an average blood glucose level of greater than 345 mg/dl in the 2- to 3-months before
study enrollment. Robert had a baseline DRC total score of 20 (score range of 14 to 70),
indicating a low level of parent-adolescent conflict surrounding the diabetes regimen. His
mother obtained a baseline DRC total score of 30, suggesting a slightly higher reported
level of parent-adolescent conflict. Robert’s total score on the SCI (score range of 14 to
70) and TADS (score range of 21 to 105) was 31 and 68, respectively. Total scores on the
SCI and TADS for his mother were 33 and 33, respectively. Ratings on the SCI and
TADS suggested less-than-ideal overall adjustment to and adherence to the medical
regimen. Robert reported the presence of frequent conflicts and arguments with his
parent(s) about completing his blood glucose checks. He also noted that he purposely did
not check his blood glucose levels at times when angry with his parent(s) or after they
had provided verbal reminders. Robert’s mother indicated arguments about a variety of
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diabetes-related issues, including blood glucose monitoring, recording levels in the log
book, eating the proper foods, and remembering to take diabetes supplies to school.
Robert most often forgot to perform his blood glucose checks before meals and at
bedtime, while hanging out with friends, when he did not want to know his level, and
when feeling sick. Robert estimated that he forgot to complete his blood glucose checks
16 to 20 times per week.
Robert’s weekly percentage adherence to blood glucose checks across meter,
baseline, and intervention phases are depicted in Figure 2. During the meter phase,
Robert’s performance was at 0 % and 4% of the recommended frequency for the 2-weeks
prior to study enrollment. During baseline, performance remained stable at 4% of the
recommended frequency for one week. Following the implementation of the intervention,
performance increased to 25% of the recommended frequency for one week, indicating a
percentage improvement of 525% from baseline to intervention. During the second and
third week of the intervention, Robert’s blood glucose meter failed, resulting in lost data.
Anecdotal reports also indicated that he did not receive all of his prompts in the secondand third-week of the intervention phase due to him being “out-of-range” while spending
vacation time in a remote location. Robert was dropped from the study after repeated
attempts to contact him by telephone were unsuccessful. Anecdotal comments obtained
from a health care team member revealed that Robert stopped participating in the study
due to time constraints, boredom, and the inconvenience of the telephone contacts and
prompts. The timing of his checks across baseline and intervention phases was also
examined. During baseline and intervention phases, none of his checks fells within the
target range.
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Mean 7-day blood glucose was not calculated for the baseline phase since Robert
only completed 1 blood glucose check (value of 432 mg/ml) during baseline. For the oneweek of the intervention phase, mean 7-day blood glucose was 425 mg/ml. Robert
obtained an A ic value of 12.8% at study enrollment. A medical chart review completed 4months after study withdrawal revealed an A ic value of 12.7%, indicating no significant
improvement in overall metabolic control. No follow-up data on blood glucose
monitoring was obtained by medical chart review.
Participant 5
Susan was a 20-year-old female diagnosed with type 1 diabetes for approximately
13 years. Susan had recently stopped attending high school after completing the 11th
grade. Susan had a total of 8 hospitalizations since diagnosis, but there were no
hospitalizations in the year before study entry. She had relatively stable, high A ic values
in the 2 years prior to study entry, ranging from 9.1 % to 11.1 %. Her pre-study A jc value
of 11.1 % indicated an average blood glucose level of approximately 310 mg/dl in the 2to 3-months before study entry. Susan had a baseline DRC total score of 18 (score range
of 14 to 70), indicating a low level of parent-adolescent conflict surrounding the diabetes
regimen. Her mother obtained a baseline DRC total score of 22, further suggesting a low
level of parent-adolescent conflict. However, qualitative analysis of individual items
revealed the presence of frequent parent-adolescent conflicts about blood glucose
monitoring. Susan’s total score on the SCI (score range of 14 to 70) and TADS (score
range of 21 to 105) was 35 and 66, respectively. Total scores on the SCI and TADS for
her mother were 37 and 65, respectively. Ratings on the SCI and TADS indicated lessthan-ideal overall adjustment to and adherence to the medical regimen. Susan most often
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forgot to complete her blood glucose checks before breakfast, when she felt fine, and
when she did not want to know her blood glucose level. Both Susan and her mother
indicated that verbal prompts were provided to encourage more consistent blood glucose
monitoring, which often resulted in Susan getting mad or angry with her parents.
Susan’s weekly percentage adherence to blood glucose checks across meter,
baseline, and intervention phases are shown graphically in Figure 2. Performance was at
21% and 14% of the recommended frequency during the meter phase. During baseline,
performance increased to 29%, indicating a percentage improvement of 38% to 107%
over pre-baseline levels. Performance increased to 61% and 57%, respectively, for the
first 2 weeks of the intervention, indicating a percentage improvement of 97% to 110%
from baseline to intervention. Performance decreased to 46% of the recommended
frequency during the third week, indicating a percentage decline of 33%. Susan dropped
out of the study after only completing 3-weeks of the intervention phase. Susan
anecdotally noted that she withdrew from the study due to time constraints and the
inconvenience of the frequent telephone contacts and prompts. Examination of the timing
of her checks across baseline and intervention phases were also completed. During
baseline, 13% of her checks fell within the target range; during the intervention phase,
20% of her checks fell within the target range, indicating a 7% improvement in the timing
of her checks.
Figure 3 shows the results of her mean 7-day blood glucose level across baseline
and intervention phases. The horizontal line represents Susan’s average blood glucose
level (Aic value of 11% = 310 mg/ml) in the 2- to 3-months preceding study entry. For
Susan, Aic values decreased from a high of 276 mg/ml during baseline, to a low of 225
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mg/ml during the 2nd week of the intervention, and increased to a high of 328 mg/ml
before dropping out. Follow-up A ic values were not available for comparison due to
Susan not showing up for a clinic visit in the 12-months following study recruitment.
Participant 6
Gretchen was a 15-year-old female diagnosed with type 1 diabetes for
approximately 13 years. She had 1 hospitalization over the last year. She had stable,
relatively high Aic values in the 2 years prior to study entry, ranging from 9.2 % to 10.7
%. Her pre-study A ic value of 10.7 % indicated an average blood glucose level of

approximately 310 mg/dl in the 2- to 3-months before study enrollment. Gretchen had a
baseline DRC total score of 26 (score range of 14 to 70), indicating a mild level of
parent-adolescent conflict surrounding the diabetes regimen. Her mother obtained a
baseline DRC total score of 17, suggesting a lower reported level of parent-adolescent
conflict. Gretchen’s total score on the SCI (score range of 14 to 70) and TADS (score
range of 21 to 105) were 39 and 69, respectively. Gretchen reported that she only
performed her blood glucose checks 25 % or less than the recommended frequency. Total
scores on the SCI and TADS for her mother were 45 and 66, respectively. As was found
with the other study participants, ratings on the SCI and TADS by Gretchen and her
mother indicated less-than-ideal overall adjustment to and adherence to the medical
regimen. Gretchen most often forgot to complete her blood glucose checks at school,
when she forgot her equipment, before dinner and bedtime, at an evening dance or party,
when hanging out with friends, and when she felt embarrassed. Gretchen noted that her
parent(s) frequently provided verbal reminders for her to complete her blood glucose
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checks more consistently. She also acknowledged that she purposely did not complete her
blood glucose checks at times when mad or angry with her parent(s).
Gretchen’s weekly percentage adherence to blood glucose checks across meter
and baseline phases are shown in Figure 2. Results indicated that Gretchen was
performing 25% and 75% of the recommended frequency during the meter phase. An
increasing trend in her performance was observed in the 1-week before study enrollment.
Performance increased to 96% during the second and third week of baseline, indicating a
percentage improvement of 28% to 284% over pre-baseline levels. Although the
intervention was implemented, no intervention data was obtained due to repeated failures
to contact Gretchen by telephone. During a follow-up telephone contact several weeks
after drop out, Gretchen indicated that the frequent telephone contacts were “too much of
a hassle” because she was “never home.” Medical chart review completed approximately
6- and 12-months after Gretchen withdrew from the study revealed that she had not
attended a scheduled clinic appointment. As such, follow-up data are not available for
comparison with baseline data.
Treatment Acceptability
Treatment acceptability ratings were obtained from one participant (Megan) and
her mother. A Likert-type scale (1 = strongly disagree to 6 = strongly agree ) was used to
assess intervention acceptability and social validity of the paging intervention. Ratings
(parent ratings are shown in italics) by Megan and her mother for several items were as
follows: this intervention increased the level of blood glucose checking (strongly agree;
agree)-, this intervention was practical in the amount of time required (agree; agree)', this

intervention improved the parent-adolescent relationship (strongly agree; slightly agree)-,
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this intervention was practical in the amount of time required to talk with the researcher
on the phone (slightly agree; agree). The overall effectiveness of the intervention was
also rated by using a Likert-type scale (1 = not effective to 10 = very effective). Both
Megan and her mother provided ratings of 8. The following two written statements were
also provided by Megan and her mother: “I got a pager to help me out and it got my A ic
down” and “The pages made my child more accountable.” Although treatment
acceptability was assessed for only one family, these preliminary findings indicate that
the intervention approach may be promising and acceptable, making it feasible to
implement in the context of a medical setting. However, as previously indicated,
adjustments to the telephone contact procedures and the number of prompts will likely be
needed to increase the overall social acceptability of the intervention.
Discussion
The primary goal of this study was to obtain preliminary data on the efficacy of
an innovative behavioral procedure designed to improve treatment adherence to the blood
glucose monitoring component of the diabetes regimen. Another aim of this study was to
test the feasibility of implementing a new intervention approach for a difficult population
(i.e., extremely poor treatment adherence) in the context of a real-world health care
setting. As with all studies, careful attention was paid to what modifications would be
needed to improve the clinical utility of the intervention. Since the extant literature shows
that few studies have focused on the actual development of new intervention strategies,
another aim of this study was to call attention to the practical problems encountered and
lessons learned. In the discussion that follows, preliminary inferences about the impact of
the intervention, limitations of the present results, the methodological and practical issues
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encountered, and cogent recommendations for the future application of the intervention
will be discussed.
The behavioral procedure used in this study provides preliminary support for
using automated paging technology to deliver prompts to increase blood glucose
monitoring. Two participants demonstrated short-term positive treatment outcomes (i.e.,
increase of 30% or greater in the frequency of blood glucose monitoring) as a function of
the paging intervention. Sara and Susan demonstrated performance increases of 36% and
33%, respectively. Robert’s more modest increase of 21% did not meet the established
criterion to be considered a positive treatment outcome. The effect of the intervention on
M egan’s performance is unclear; however, the 7% increase in performance at the onset of
the intervention and the decreasing trend found during prompt fading provides some
evidence, albeit limited, that the intervention may have had some impact on her behavior.
There was also a 10% improvement in the timing of her blood glucose checks during
intervention. Modest improvements in the timing of blood glucose checks were also
found for Sara and Susan. Sara demonstrated a 10% improvement in the timing of her
checks, while Susan showed a 7% improvement. Five participants also demonstrated
noticeable increases in blood glucose monitoring (i.e., ceiling effect) during baseline or
immediately before study entry. The implications of this finding will be discussed in a
later section of this discussion. Intervention effects for two participants, Debra and
Gretchen, could not be evaluated due to early drop out.
Although not directly targeted, another aim of this study was to assess for positive
health outcomes. Preliminary data indicated that two participants demonstrated clinically
significant improvements in metabolic control. Megan demonstrated a substantial
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decrease of 118 mg/ml in her mean 7-day blood glucose levels from baseline to
intervention. Susan demonstrated a more modest change of 51 mg/ml. The 1.6%
reduction in M egan’s hemoglobin A ic value also supported a long-term positive health
outcome. Although Debra was dropped from the study before completing the
intervention, she also demonstrated a 0.9 % reduction in her A ic value at a 3-month
follow-up. Reductions of A ic values in the range of 1% to 2% are considered to be
clinically significant as even these small changes in metabolic control have been
associated with a 26% to 76% decrease in long-term negative health complications
(DCCT, 1993). Despite Sara and Robert exhibiting performance increases during
intervention, there is no evidence that these changes lead to improvements in metabolic
control, thus mitigating definite conclusions that the intervention reliably produced
positive health outcomes for these two participants. This finding is consistent with
previous research that raises uncertainty about the existence of a veridical relationship
between treatment adherence and positive health outcomes (Rapoff & Barnard, 1991).
Examination of Robert’s Aic value at follow-up did not show any positive improvement
in metabolic control. For Sara, Susan, and Gretchen, follow-up Aic values were not
available for comparison.
Preliminary findings from this study indicate that the antecedent prompting
procedure may be a feasible treatment option for increasing blood glucose monitoring
and improving metabolic control in the short-term. However, conclusions about the
impact of the intervention are tentative and inconclusive in light of several
methodological problems, including ceiling effects, early drop out from the study, failure
to complete the entire intervention, failure to return to baseline levels, and lack of follow-
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up data. Although initial data provide some preliminary support for the short-term
effectiveness of the intervention, the limitations of the present findings as well as the
methodological and practical issues encountered need to be more fully addressed.
Visual inspection appears to support a short-term veridical change in Sara’s,
Robert’s, and Susan’s performance at the onset of the intervention; however, there may
be other plausible behavioral explanations for these performance changes. One potential
explanation to consider is that the baseline and intervention phases did not remain distinct
from each other. In this study, parents were not specifically asked to make any changes in
their parenting behaviors due to concerns that this would decrease the quality of parental
supervision over the medical regimen. However, unknown changes in the parents’
behaviors may account for the performance increases found with Sara, Robert, and
Susan. For example, when the intervention was introduced, the parents may have
inadvertently increased their level of parental monitoring, perhaps due to an increased
interest in the potential effects of the intervention. The extant literature has indeed
documented a positive association between parental monitoring and treatment adherence.
The parents may have also increased their use of contingent praise or rewards (i.e.,
reinstatement of privileges), even if the intervention produced some initial positive
changes in performance. Although parent behavior was not formally assessed, anecdotal
comments obtained from the parents implied that they did not make any significant
changes in their parenting behaviors. Parents were also instructed at study enrollment to
not make any specific changes to their usual parenting practices. Given the immediacy
and magnitude of the performance change with Sara and Susan at the onset of the
intervention, a fairly strong case can be made that the intervention rather than other
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extraneous events (i.e., history, reactivity) led to the performance changes. In addition,
given the prolonged history of poor compliance and the lack of improvement from other
clinic-based intervention strategies for these two participants, it is plausible that the short
term performance increases were accounted for by the intervention. However,
demonstrating performance changes without returning to baseline levels limits definite
conclusions about the impact of the intervention.
Another plausible explanation for the performance increases may have been due
to two operating reinforcement contingencies such as negative and positive
reinforcement. For example, as will be discussed later in this discussion, the arrival of
the prompt before the blood glucose check was actually performed may have functioned
as an aversive condition for some of the participants. As such, the participants may have
performed the blood glucose check to avoid the presentation of the aversive condition
(i.e., no blood glucose check performed when the prompt arrives). If the blood glucose
check was performed before the prompt arrived, then the prompt may have functioned as
a positive reinforcer.
One problem encountered in the implementation of this study was the ceiling
effects obtained during the baseline phase. At the outset, this study planned on using a
concurrent multiple-baseline design across individuals to avoid the practical issues
related to withdrawing the intervention and returning to baseline. However, due to ceiling
effects during baseline, this design was not feasible as the conditions of the design would
not be met. With the exception of Robert, all participants displayed noticeable increases
in blood glucose monitoring either during baseline or immediately before study
enrollment. Even with the use of a probe-assessment technique and a prolonged baseline,
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performance remained relatively stable and no regression towards the mean was
observed. This may have been due to problems with reactive assessment or multipletreatment interference (i.e., the telephone contacts functioned as a treatment component).
Interestingly, the ceiling effects imply that modest performance increases can be obtained
by conducting telephone contacts similar to the ones used in this study. This finding is
consistent with previous research that has demonstrated that telephone prompts can
facilitate increased adherence behaviors (La Greca & Schuman, 1995).
Performance increases during baseline may have also attenuated the intervention
effects found with Megan, Sara, and Susan. There are several plausible explanations for
the observed performance increases during baseline. Expectancy effects during the
baseline phase may have led to systematic changes in blood glucose checking. The
participants may have been influenced during baseline by the increased awareness that
their performance was being more closely monitored. As previously mentioned, the
telephone contacts used during baseline may have inadvertently functioned as a treatment
component. Another potential explanation is that the participants established a rule
statement (i.e., establishing operation) during baseline to earn a delayed, reinforcing
consequence (i.e., access to a free pager service). Anecdotal comments indicated that
Megan was strongly motivated to obtain access to the free paging service. It is also
noteworthy to point out that the majority of the participants asked for clarification on
when the pager would be activated. Although not directly assessed in this study, the
establishment of a rule statement cannot be discounted as a positive motivating condition
for the increased blood glucose checking found during the baseline phase. Similarly, it is
not unreasonable to hypothesize that a rule statement (e.g., “If I continue checking by
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blood glucose levels, I can continue to use this free paging service”) will be able to
continue or other unknown motivating condition, rather than the prompts alone, were
responsible for the performance increases found in Sara, Susan, and Robert during the
intervention phase.
Methodological Issues
There are several limitations to this study that need to be addressed. As with all
studies, the small sample size and a lack of a control group limit the generalization of
results. Other limitations of this study included high participant attrition, failure to
complete the entire intervention and return to baseline due to early study drop out, and
inconsistent follow through with scheduled clinic visits. Three of the six participants
enrolled in this study failed to show-up for a scheduled clinic appointment in the 12months following withdrawal or being dropped from the study. Of the three participants
who showed-up for a clinic visit, no follow-up data on blood glucose monitoring was
obtained by medical chart review, making it difficult to assess for maintenance effects or
to cross-check for accuracy of verbal reporting. Anecdotal comments from health-care
team members revealed a variety of reasons for the lack of follow-up data, including
forgetting to bring-in the blood glucose monitor, failure to download the monitor data due
to time constraints, and software malfunctions during downloads. Our clinic observations
indicate that it is not unusual for patients to forget to bring-in their blood glucose
monitors. In addition, the downloading of monitor data during clinic visits is often
complicated by software malfunctions as many monitor models require their own
designated software program. Unfortunately, critical errors often occur during the
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downloading process due to the software program not matching-up with the model type,
which further complicates the collection of reliable follow-up data.
The unreliability of the data collection procedure used in this study also needs to
be addressed. Frequency of blood glucose monitoring was obtained by verbal self-report
during scheduled telephone contacts. To encourage accurate and honest self-reporting,
participants were asked to have their blood glucose monitors in-hand during telephone
contacts in order to precisely report the exact date, time, and blood glucose level of each
check. Participants were also told that the investigator would perform medical chart
reviews to cross-check for accuracy of self-reporting. Unfortunately, due to the lack of
follow-up data on blood glucose monitoring, inter-observer reliability checks could also
not be calculated to determine the accuracy of self-reporting. Although we do not have
any direct evidence, we cannot discount the possibility that the participants provided
socially desirable responses during the telephone contacts.
Along similar lines, we did not directly verify if the participants were in fact
carrying the electronic pagers with them at all times or if the pagers remained on. This is
particularly concerning since several of the participants noted that the daily prompts
became too burdensome and time-consuming. Although it was thought that access to a
free paging service would create built-in incentives for consistent carrying of the pagers,
there was no procedures in-place to rule-out this potential threat to internal validity. In
the initial planning stages, the option of using two-way electronic pagers was considered,
but was later dropped from the final research design due to the increase costs and more
sophisticated technology.
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Another limitation of this study is the high attrition rate. Only one participant
completed the entire intervention phase, which raises serious questions about the
appropriateness of the telephone contacts and/or prompts used in this study. Several of
the participants anecdotally noted several factors (i.e., time constraints, annoyance with
the telephone contacts and/or prompts) that interfered with their commitment to the study
protocol. Attrition problems may have also been related to the prompts functioning as a
learned aversive stimulus for the participants. Follow-up data obtained by medical chart
review also did not reveal any significant improvements in metabolic control for the
dropped participants, suggesting that those with more poorly controlled diabetes may be
less likely to adhere to the study protocol. Yet, it should be noted that several of the
participants who elected to enroll in this study had repeatedly declined invitations in the
past to participate in more conventional clinic interventions and research projects. The
novelty of the behavioral approach (i.e., prompts) used in this study may have helped to
recruit a subgroup of patients who had previously declined to participate in any form of
intervention. However, important modifications to the intervention procedures will be
needed in the future to reduce problems with attrition rates as well as improve the social
acceptability of the intervention.
Advantages of Antecedent Prompting Procedure
Despite the aforementioned limitations, there are several advantages of the
behavioral procedure that should be discussed. Since the prompts could be delivered
through automated paging technology, the antecedent prompting procedure relied less on
extensive patient, parent, and health-care team involvement. Less than 15 minutes was
typically needed during the office-based visit to hand-out and to explain how to use the
electronic pager. Prompts delivered through automated paging technology may also be
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relatively cost-effective. The costs of the pager and the monthly service were relatively
inexpensive, only costing $19.95 per month. Costs could be further reduced by removing
the statewide and national coverage plans that were used in this study. Prompts could also
prove to be a viable and cost-effective treatment option for reducing the risk of
hospitalization in the short-term. For example, during times of physical illness, emotional
distress, and adolescent puberty, the action or efficiency of insulin is often compromised,
thus requiring some minimal level of blood glucose monitoring to prevent hypo- or
hyperglycemic episodes. Another added benefit is that the patient is encouraged to take
increased individual responsibility of the medical regimen. Prompts delivered through
automated paging technology are particularly well-suited in situations where there is
increased pressure by the health care team or families for more independence. In
addition, since automated paging technology is portable, prompts have an added benefit
of promoting adherence when the young patient is away from home and receiving less
parental monitoring. Several participants in this study reported that they forgot to perform
blood glucose monitoring checks at school, suggesting that prompts may be particularly
useful in the school setting. A final advantage is related to the novelty of using automated
paging technology to deliver prompts designed to improve treatment adherence. Several
of the participants who had declined previous offers to participate in alternate clinicbased treatment options elected to participate in this study. Overall, this behavioral
procedure has several advantages, including a strong interest by parents and youngsters in
an innovative treatment approach, its simplicity and portability, and the potential
reduction of short-term health risks.
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Implications for Future Research
Since an aim of this study was to consider what modifications would be needed to
successfully implement the intervention in the context of a real-world medical setting, it
was also important to identify ways in which to modify the research design and
intervention procedures for use with this population. Several recommendations for the
future application of the intervention will be discussed here.
Specific modifications to the research design are needed to prevent the ceiling
effects found during baseline in this study. Ceiling effects during baseline prevented the
use of the multiple-baseline design across participants, a design that avoids the practical
issues of temporarily withdrawing the intervention. One option is to use the downloaded
data from the blood glucose monitors to establish the baseline phase and to immediately
implement the intervention (i.e., prompts). However, this may not entirely eliminate
ceiling effects, since ceiling effects and increasing trends in performance can also be
found in the weeks before study enrollment. A second option is to eliminate all telephone
contacts and to collect all study data by downloading the monitors at a follow-up officebased visit. If downloaded monitor data indicate that performance is already close to a
zero rate before study entry, it may also be unpractical to establish a baseline level of
performance. When the rate of blood glucose monitoring is already near zero, immediate
intervention may be called for, particularly in light of the significant health risks
associated with extreme noncompliance to this component of the diabetes regimen.
Another option to consider in future studies is to use an alternative research
design such as the changing-criterion design. Although this design requires a baseline
phase, no withdrawal or withholding of the prompts would be needed to demonstrate the
effect of the intervention. If the option to immediately start the intervention is selected
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without first establishing a baseline phase, then it may be a reasonable option to proceed
as a BABA design. However, the ethical issues of using phase reversals in research in
the area of treatment adherence needs to be carefully considered. If the prompts lead to
significant improvements in blood glucose monitoring, important ethical issues are raised
about withdrawing the intervention and returning to baseline levels. Although phase
reversals are often needed to clarify the impact of the intervention, attempting to return
behavior back to a baseline level may not be in the best interest of patients diagnosed
with a chronic medical condition, since this may result in serious, deleterious health
consequences. The use of phase reversals in this population raises important questions
about the clinical practicality of applying ABAB or similar designs. Unfortunately, as
was found in this study, unanticipated research design problems resulted in inconclusive
findings about the impact of the prompts on blood glucose monitoring and interfered with
ruling-out other threats to internal validity.
Modifications to the data collection and/or intervention procedures are also
needed to improve participation rates, reduce the research demands, and to improve the
social acceptability of the prompts. Anecdotal reports indicated that the weekly telephone
contacts and prompts may have been too time-consuming, burdensome, and
overwhelming for several participants. The study protocol may have had the unfortunate
effect of adding another treatment component to an already complex medical regimen.
Reducing the frequency of telephone contacts or using alternative data collection
procedures may help to reduce research demands and improve overall retention rates. For
example, the use of blood glucose monitors with built-in wireless technology, albeit more
costly, would simplify the data collection process and reduce time constraints as the data
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would be automatically sent from the monitor to the investigator for analysis. Wireless
technology would also allow the use of optional intervention procedures. For example,
analysis of the data in real-time may reveal dramatic improvements in blood glucose
monitoring and metabolic control over a period of time, which could be reinforced by
sending a “bonus” prompt (e.g., “Keep up the excellent work. You’re blood glucose
checks and levels look great”).
Adding other reinforcement-based procedures (i.e., monetary rewards, small gifts)
may also enhance participation in the telephone contacts and minimize participant
attrition. The optimal number of prompts required to obtain a desired positive treatment
outcome should also be determined in future research. Fewer prompts (i.e., 1 versus 4 per
day) may produce similar treatment outcomes while reducing other potential threats to
internal validity, including maturation factors (i.e., tiredness, boredom). Preliminary
findings suggested that the prompts improved the timing of the blood glucose checks by
7% to 10% for several of the participants. Since the timing of blood glucose checks are
just as important as the frequency of checking, a randomized procedure of the times
could be used to not only reduce the total number of prompts, but also to ensure that
patients are randomly paged at the appropriate times. Perhaps only 3 random pages or
less per week would be effective in improving blood glucose monitoring while reducing
the risk of the prompts becoming an aversive stimulus.
In future studies, the patients and families who decline to participate or withdraw
early should also be closely assessed to shed light on the potential limitations of using
this behavioral procedure in this population. As Riekert and Drotar (1999) point out,
when conducting research on treatment adherence, the research demands need to be
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appropriately adjusted and/or modified in order to make participation more convenient,
less time consuming, and to improve participant retention rates across all experimental
conditions. A modification that was helpful for one study participant (i.e., Sara) involved
adjusting the frequency and timing of the telephone contacts. During the intervention
phase, Sara indicated that she was contemplating her withdrawal from the study due to
time constraints. However, after minor adjustments were made to the time of the
telephone contacts, particularly during busier weeks, she elected to remain in the study
for a longer period of time.
Another important future consideration is to ensure that participants are provided
with adequate and dependable diabetes supplies (e.g., blood glucose monitors, testing
strips) before study entry. Each participant in future studies should also be provided with
the same brand of blood glucose monitor in order to prevent software malfunctions and to
encourage reliable data collection. For one participant (Gretchen), significant financial
barriers were also encountered after her health insurance was unexpectedly dropped,
which resulted in her paying out-of-pocket expenses for medical supplies. During the
intervention phase, Gretchen quickly depleted her supply of testing strips, which
effectively prevented her from performing her blood glucose checks. This not only
resulted in the loss of valuable intervention data, but it also created a potentially
dangerous health situation for Gretchen. Likewise, participants should be provided with
new blood glucose monitors with adequate built-in memory capabilities in order to store
large amounts of data and to reduce the risk of monitor failures. The importance of
providing participants with reliable monitors was evident after one participant’s (Robert)
monitor stopped working properly. These real-life examples not only reveal the
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importance of ensuring that participants have adequate medical supplies at study entry,
but they also illuminate some of the practical issues commonly encountered in
conducting applied research with this population.
The use of two-way paging technology in future studies will also help to address
concerns that participants turn off the pagers or do not consistently carry them. By using
two-way paging technology, patients could be required to send back confirmation
prompts, perhaps on a random basis, in order to determine if the prompts were actually
received. The use of two-way paging technology may also be more feasible in the future
as the costs of this type of technology are significantly decreasing. In addition, many
cellular phones available on the market today have built-in two-way text paging
capabilities. Providing patients with cellular phones with built-in text paging technology
may also be a more acceptable treatment option as cellular phones tend to be more
popular among youth in contrast to standard paging technology. Developing contingency
management procedures to control the participant’s access to the free service should also
be considered in future research. For example, a behavioral contingency could be
arranged in which the patient would be required to achieve a predetermine criterion level
(i.e., 28 checks per week) in order to earn access to the cellular phone or paging service.
If the performance criterion was not reached, arrangements could be made to temporarily
disconnect the service or the parents could be asked to remove the patient’s access
through a penalty procedure (i.e., temporary loss of access to the service).
Future studies should also attempt to replicate these initial findings with a larger
sample size and obtain long-term follow-up assessments to assess for maintenance
effects. Replication of this study across research sites, patients, and different medical

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

regimens (i.e., asthma) would also likely increase the external validity of findings.
Although this study recruited patients with extremely poor treatment adherence, future
studies should also consider applying the intervention to populations with less severe
treatment noncompliance. It was assumed that patients with very poor treatment
adherence would be most likely to acquire positive health outcomes from the prompts;
however, it is not unreasonable to hypothesize that patients with less severe treatment
noncompliance would also benefit from prompting procedures. Although the participants
enrolled in this study had poor metabolic control (i.e., A ic values ranged from 9% to
12%) at study entry, a predetermined A ic value was not a required enrollment criterion
for eligibility. Future studies should consider recruiting only those patients with
abnormally high Aic values. Perhaps only patients with higher A ic values (i.e., A ic values
over 14%) would benefit the most from the intervention approach.
Efforts also need to be made to collect more objective data to assess the impact of
the intervention on other diabetes-related behaviors that may affect metabolic control.
Pilot data was collected in this study for descriptive purposes and to qualitatively
evaluate whether or not the intervention had any ancillary impact on other diabetesrelated tasks. Participants in this study were asked to informally report the number of
days per week that they adhered to other diabetes-related tasks (i.e., diet, insulin
injection, exercise). Informal inspection of these ratings did not reveal any noteworthy
performance changes to the other diabetes-related tasks. No participant indicated any
significant problems with performing daily insulin injections. This is consistent with
clinic observations that relatively few patients with type 1 diabetes neglect to perform the
insulin replacement component of the diabetes regimen. However, the number of days in
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which participants adhered to the dietary and exercise components of the medical
regimen were more variable and often less-than-ideal.
Additional data will also be needed to evaluate the impact of the prompts on the
overall level of treatment adherence, parent-adolescent conflict, and adjustment/coping to
the medical regimen. Unfortunately, due to participant attrition, loss of contact with
participants, and refusal to complete the questionnaires at study dropout, follow-up
questionnaire data was obtained for only one participant (Megan) and her mother. For
Megan, there was only negligible improvement in her overall adjustment and level of
treatment adherence to the diabetes regimen. Although follow-up questionnaire data was
only collected on one participant, these results are consistent with previous research that
has shown that improvement to one treatment component (i.e., blood glucose monitoring)
does not necessary imply that concomitant changes will be found with the other regimen
tasks (Johnson, 1995).
In contrast, the 35-point drop found in Megan’s DRC score from pre- to post
intervention indicated that Megan was reporting a significant reduction in the level of
parent-adolescent conflict surrounding the diabetes regimen. This finding may indicate
that the prompts had more widespread behavioral effects on the overall family system for
Megan and her family. Despite the lack of follow-up data on the level of parentadolescent conflict for the other participants, most of the families reported a high level of
parent-adolescent conflict surrounding the diabetes regimen at study entry. The majority
of the participants also noted that they had become angry with their parent(s) when
reminded to perform blood glucose monitoring checks. In fact, several participants
reported that they had intentionally not performed blood glucose checks when mad or
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angry with their parent(s). In future studies, it may be beneficial to consider adding an
additional treatment component by asking parents to refrain from providing verbal
prompts to their adolescent in order to allow the prompts to temporarily replace the
negatively viewed parental reminders. If prompts can be used to temporarily reduce
negative behavioral exchanges, the frequency of parent-adolescent conflicts may decline,
which may further enhance treatment adherence. Another option is to add the prompts to
an already existing treatment package such as Behavioral Family Systems Therapy
(BFST). Perhaps adding prompts to the BFST family therapy approach would produce
more immediate improvements in treatment adherence by more quickly reducing the
level of parent-adolescent conflict (Wysocki et al., 2001).
Since the extant literature suggests that reminders alone (i.e., visual or verbal
prompts) may be inadequate in improving adherence levels for some patients, additional
reinforcement-based contingencies in addition to the prompts should also be considered
to improve treatment adherence (La Greca & Schuman, 1995). For this study, we were
specifically interested in using an antecedent prompting procedure due to its simplicity
and relatively ease of being implemented in the context of a real-world medical setting.
However, reinforcement-based procedures would likely increase patients’ and families’
participation in the study protocol. In addition, adding a reinforcement-based procedure
(i.e., earn $1 if a blood glucose check is completed in a timely manner) in addition to the
prompts may produce more significant treatment outcomes. Withdrawal of the reward
contingency, perhaps through a sequential-withdrawal design, would also allow direct
examination of the effects of alternating the two treatment components (i.e., prompts
versus reinforcement) on performance.

62

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Future Adaptations of Antecedent Prompting Intervention
One adaptation to consider in future studies is to use prompts, perhaps in the form
of tactile prompts (i.e., vibrating), with youngsters in the school setting. For many
younger patients with type 1 diabetes, there is often an important transition period in
which responsibility for performing the blood glucose checks is transferred from school
officials to the youngster. Before this transitional period, the onus often falls on school
officials (i.e., school nurse, teachers) to provide reminders and ensure that the checks are
being completed. In situations in which health care team members and families would
like to transfer increased responsibility to the youngster, providing a supplemental
stimulus in the form of a tactile prompt may facilitate a smoother transition period. Even
with modest, short-term performance increases in blood glucose monitoring, prompts
delivered through automated paging technology may be a time-efficient and portable
intervention approach to promote increased independence during this transitional period.
Adding a reinforcement-based contingency (i.e., teacher provides a small reward if the
child completes the blood glucose check after receiving the prompt) may further help to
increase and maintain independent blood glucose monitoring. In addition, attempts could
be made to gradually reduce the prompts and/or reinforcement-based procedure to
evaluate whether or not appropriate rates of blood glucose monitoring would be
maintained over time.
Although this study assessed the impact of the intervention on patients diagnosed
with type 1 diabetes, the intervention could also be adapted for use with other
populations. For example, when expectant mothers are diagnosed with gestational
diabetes, it is imperative that they continually monitor their blood glucose levels as this
may lead to serious, immediate negative health consequences for the fetus. Since these

63

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

mothers are likely to be quite unfamiliar with an acute, short-term medical regimen,
providing prompts to remind them to complete blood glucose checks in a timely fashion
may be quite useful. Similarly, it may also be beneficial to apply the intervention in
populations (i.e., elderly, traumatic brain injury) that respond less favorably to naturally
occurring contingencies.
Conclusions
Despite the limitations and methodological issues encountered, this study is the
first to our knowledge to use automated paging technology to deliver prompts designed to
increase adherence to an individual treatment component of the diabetes regimen. Also,
relatively few studies to date have attempted to document the efficacy of interventions by
presenting quantitative data (i.e., blood glucose levels) to assess for positive treatment
health outcomes. Although preliminary findings are tentative and modest, this does not
necessarily imply that even small performance changes are not clinically significant.
Even with small changes in the frequency of blood glucose checking, significant
improvements in the quality of diabetes management may be obtained. For example,
adding only 1 extra blood glucose check per day may allow a patient to make a clinically
important adjustment to the insulin level, which may in effect lower blood glucose levels
for an extended period of time. If this check was not completed, blood glucose levels may
have remained too high or low resulting in increased risk for negative health-outcomes
such as hospitalization. The findings from this study are also novel in that this is the first
known study to demonstrate that poor compliance to a specific component of a medical
regimen can be improved in the short-term by delivering antecedent prompts through
automated paging technology.
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In conclusion, this study finds that extreme noncompliance to a specific treatment
component of a chronic medical condition may be amendable to a simple antecedent
prompting procedure (i.e., prompts) delivered through automated paging technology. For
three participants studied, an antecedent prompting procedure was somewhat successful,
albeit of limited duration, in increasing blood glucose checking. Two participants also
demonstrated improved metabolic control (i.e., reduction in blood glucose levels).
Although the prompts may have only improved blood glucose monitoring in the short
term, these improvements could be framed for families as temporary motivational
conditions to increase treatment adherence to a point where natural reinforcers (i.e.,
improved health outcomes, praise from parents or health-care team members) begin to
function as effective consequences for continued adherence.

65

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

References
Anderson, B. J., Brackett, J., Ho, J., & Laffel, L. M. B. (1999). An office-based
intervention to maintain parent-adolescent teamwork in diabetes management.
Diabetes Care, 22, 713-721.
Anderson, B. J., Auslander, W. F., Jung, K. C., Miller, J. P., & Santiago, J. V. (1990).
Assessing family sharing of diabetes responsibilities. Journal of Pediatric
Psychology, 15, 477-492.
Anderson, B. J., Wolf, F. M., Burkhart, M. T., Cornell, R. G., & Bacon, G. E. (1989).
Effects of peer-group intervention on metabolic control of adolescents with IDDM:
Randomized outpatient study. Diabetes Care, 3, 179-183.
Amett, J. J. (1999). Adolescent storm and stress, reconsidered. American Psychologist,
54,317-326.
Auslander, W. F., Anderson, B. J., Bubb, J., Jung, K. C., & Santiago, J. V. (1990). Risk
factors to health in diabetic children: A prospective study from diagnosis. Health
Sociology Work, 15, 133-142.
Austin, J., Alvero, A. M., & Olson, R. (1998). Prompting patron safety belt use at a
restaurant. Journal of Applied Behavior Analysis, 31, 655-658.
Baum, D., & Creer, T. L. (1986). Medication compliance in children with asthma.
Journal of Asthma, 23, 49-59.
Barlow, D. H., & Hersen, M. (1984). Single-case experimental designs: Strategies for
studying behavior change (2nd ed.). New York: Pergamon Press.
Barnett, A., Eff, C., Leslie, R., & Pyke, D. (1981). Diabetes and heart disease. In M.
Harris & R. Hamman (Eds.), Diabetes in America (NIH Publication no. 95-1468, pp.
XVI: 1-41). Bethesda, MD: National Institutes of Health.
Becker, M. H., Drachman, R. H., & Kirscht, J. P. (1972). Predicting mothers’
compliance with pediatric medical regimens. Journal of Pediatrics, 81, 843-854.
Berlant, N. E. (2004). Increasing adherence to an exercise intervention. (Doctoral
dissertation, University of Florida, 2004). Dissertation Abstracts International, 65,
2612.
Bijou, S. W., Peterson, R. F., Harris, F. R., Allen, K. E., & Johnston, M. S. (1969).
Methodology for experimental studies of young children in natural settings.
Psychological record, 19, 177-210.
Bobrow, E. S., AvRuskin, T. W., & Siller, J. (1985). Mother-daughter interactions and
adherence to IDDM regimens. Diabetes Care, 8, 146-151.

66

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Carney, R. M., Schechter, K., & Davis, T. (1983). Improving adherence to blood
glucose testing in insulin dependent diabetic children. Behavior Therapy, 14, 247254.
Da Costa, I. G., Rapoff, M. A., Lemanek, K., & Goldstein, G. L. (1997). Improving
adherence to medication regimens for children with asthma and its effect on clinical
outcome. Journal of Applied Behavior Analysis, 30, 687-691.
Delamater, A. M., Albrecht, D. R., Postellon, D. C., & Gutai, J. P. (1991). Racial
differences in metabolic control of children and adolescents with type 1 diabetes
mellitus. Diabetes Care, 14, 20-25.
Delamater, A. M., Shaw, K. H., Applegate, E. B., Pratt, I. A., Eidson, M., Lancelotta, G.
X. et al. (1999). Risk for metabolic control problems in minority youth with diabetes.
Diabetes Care, 22, 700-705.
Diabetes Control and Complications Trial (DCCT) Research Group. (1994). Effect of
intensive diabetes treatment on the development and progression of long-term
complication in adolescents with insulin-dependent diabetes mellitus: Diabetes
Control and Complications Trial. The Journal of Pediatrics, 125, 177-188.
Dorman, J., & LaPorte, R. (1985). Mortality in insulin-dependent diabetes. In M. Harris
& R. Hamman (Eds.), Diabetes in America (NIH Publication No. 95-1468, pp.
XXX: 1-9). Bethesda, MD: National Institutes of Health.
Drotar, D. (1995). Consultation with pediatricians. New York: Plenum Press.
Drotar, D., & Lemanek, K. (2001). Steps toward a clinically relevant science of
interventions in pediatric settings: Introduction to the special issue. Journal of
Pediatric Psychology, 26, 385-394.
Engerman, J. A., Austin, J., & Bailey, J. S. (1997). Prompting patron safety belt use at a
supermarket. Journal of Applied Behavior Analysis, 30, 577-579.
Finney, J. W., Lemanek, K. L., Brophy, C. J., & Cataldo, M. F. (1990). Pediatric
appointment keeping: Improving adherence in a primary care allergy clinic. Journal
of Pediatric Psychology, 15, 571-579.
Geller, S. E., Johnson, R. P., & Pelton, S. L. (1982). Community-based interventions for
encouraging safety belt use. American Journal of Community Psychology, 10, 183196.
Gilbert, B. O., Johnson, S. B., Spillar, R., McCallum, M., Silverstein, J. H., &
Rosenbloom, A. (1982). The effects of a peer-modeling film on children learning to
self-inject insulin. Behavior Therapy, 13, 186-193.

67

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Greco, P., La Greca, A. M., Auslander, W. F., Spetter, D., Skyler, J. S., Fisher, E. et al.
(1990). Assessing adherence in EDDM: A comparison of two methods. Diabetes, 40
(supp. 2), 108A (abstract).
Greenan-Fowler, E., Powell, C., & Vami, J. W. (1987). Behavioral treatment of
adherence to therapeutic exercise by children with hemophilia. Archives of Physical
Medicine and Rehabilitation, 68, 846-849.
Gross, A. M., Magalnick, L. J., & Richardson, P. (1985). Self-management training with
families of insulin-dependent diabetic children: A controlled long-term investigation.
Child & Family Behavior Therapy, 7, 35-50.
Gustafsson, P., Cederblad, M., Ludvigsson, J., & Lundin, B. (1987). Family interaction
and metabolic balance in juvenile diabetes mellitus: A prospective study. Diabetes
Research and Clinical Practice, 4, 7-14.
Harris, M. A., Greco, P., Wysocki, T., & White, N. H. (2001). Family therapy with
adolescents with diabetes: A litmus test for clinically meaningful change. Families,
Systems, & Health, 19, 159-168.
Hauser, S. T., Jacobson, A. M., Lavori, P., Wolfsdorf, J. I., Herskowitz, R. D., Milley, J.
E. et al. (1990). Adherence among children and adolescents with insulin-dependent
diabetes mellitus over a four year follow-up. II: Immediate and long term linkages
with the family milieu. Journal of Pediatric Psychology, 15, 527-542.
Haynes, R. B. (1979). Introduction. In R. B. Haynes, D. W. Taylor, & D. L. Sackett
(Eds.), Compliance with health care (pp. 1-7). Baltimore: John Hopkins.
Holden, E. W., Deichmann, M., & Levy, J. D. (1999). Empirically supported treatments
in pediatric psychology: Recurrent pediatric headache. Journal of Pediatric
Psychology, 24, 91-109.
Howard, K. I., Moras, K., Brill, P. L., Martinovich, Z., & Lutz, W. (1996). Evaluation of
psychotherapy: Efficacy, effectiveness, and patient progress. American Psychologist,
51, 1059-1064.
Janicke, D. M., & Finney, J. W. (1999). Empirically supported treatments in pediatric
psychology: Recurrent abdominal pain. Journal of Pediatric Psychology, 24, 115128.
Johnson, S. B. (1995). Insulin-dependent diabetes mellitus in childhood. In M. C.
Roberts (Ed.), Handbook of pediatric psychology (2nd ed., pp. 263-285). New York:
Guilford.

68

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Johnson, S. B., Poliak, T., Silverstein, J. H., Rosenbloom, A. L., Spillar, R., McCallum,
M., et al. (1982). Cognitive and behavioral knowledge about insulin dependent
diabetes among children and parents. Pediatrics, 69, 708-713.
Johnson, S. B., Silverstein, J., Rosenbloom, A., Carter, R., & Cunningham, W. (1986).
Assessing daily management of childhood diabetes. Health Psychology, 5, 545-564.
Kazdin, A. E. (1982). Single-case research designs: Methods for clinical and applied
settings. New York: Oxford.
Kelleher, K. J. (1999). Commentary: Pediatric psychologist as investigator in primary
care. Journal of Pediatric Psychology, 24, 459-462.
Kenny, S. J., Aubert, R. E., & Geiss, L. S. (1995). Prevalence and incidence of non
insulin-dependent diabetes. In National Diabetes Data Group (Eds.), Diabetes in
America (2nd ed., pp. 47-67). Washington, DC: National Institutes of Health.
Killam, P. E., Apodaca, L., Manella, K. J., & Vami, J. W. (1983). Behavioral pediatric
weight rehabilitation for children with myelomeningocele. MCN: American Journal
of Maternal Child Nursing, 8, 280-286.
Kovacs, M., Goldston, D., Obrosky, D. S., & Iyengar, S. (1992). Prevalence and
predictors of pervasive noncompliance with medical treatment among youths with
insulin-dependent diabetes mellitus. Journal of the American Academy of Child and
Adolescent Psychiatry, 31, 1112-1119.
Krantz, P. J., & McClannahan, L. E. (1993). Teaching children with autism to initiate to
peers: Effects of a script fading procedure. Journal of Applied Behavior Analysis, 26,
121-132.
La Greca, A. M. (1990). Issues in adherence with pediatric regimens. Journal of
Pediatric Psychology, 15, 423-436.
La Greca, A. M., & Schuman, W. B. (1995). Adherence to prescribed medical regimens.
In M. C. Roberts (Ed.), Handbook of pediatric psychology (2nd ed., pp. 55-83). New
York: Guilford.
La Greca, A. M., & Skyler, J. S. (1991). Psychosocial issues in EDDM: A multivariate
framework.
In P. McCabe, N. Schneiderman, T. Field, & J. S. Skyler (Eds.), Stress, coping, and
disease (pp. 169-190). Hillsdale, NJ: Erlbaum.
Lancioni, G. E., O ’Reilly, M. F., Campodonico, F. (2002). Promoting fluency of
performance of self-help tasks with a person with multiple disabilities. Behavioral
Interventions, 17, 15-20.

69

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LaPorte, R. E., & Cruickshanks, K. (1985). Incidence and risk factors for insulindependent diabetes. In M. Harris & R. Hamman (Eds.), Diabetes in America (NIH
Publication No. 95-1468, pp. 111:1-2). Bethesda, MD: National Institutes of Health.
LaPorte, R. E., Matsushima, M., & Chang, Y. F. (1995). Prevalence and incidence of
insulin-dependent diabetes. In National Diabetes Data Group (Eds.), Diabetes in
America (2nd ed., pp. 37-46). Washington, DC: National Institutes of Health.
LaPorte, R. E., & Tajima, N. (1985). Prevalence of insulin-dependent diabetes. In M.
Harris & R. Hamman (Eds.), Diabetes in America (NIH Publication No. 95-1468, pp.
V :l-8). Bethesda, MD: National Institutes of Health.
Lemanek, K. L. (1990). Adherence issues in the medical management of asthma.
Journal of Pediatric Psychology, 15, 437-458.
Lemanek, K. L., Kamps, J., Chung, N. B. (2001). Empirically supported treatments in
pediatric psychology: Regimen adherence. Journal of Pediatric Psychology, 26, 253275.
Litt, I. F., & Cuskey, W. R. (1980). Compliance with medical regimens during
adolescence. Pediatric Clinics of North America, 27, 1-15.
Lorenz, R. A., & Wysocki, T. (1991). From research to practice: The family and
childhood diabetes. Diabetes Spectrum, 4, 261-292.
Lowe, K., & Lutzker, J. R. (1979). Increasing compliance to a medical regimen with a
juvenile diabetic. Behavior Therapy, 10, 57-64.
Magrab, P. R., & Papadopoulou, Z. L. (1977). The effects of a token economy on
dietary compliance for children on hemodialysis. Journal of Applied Behavior
Analysis, 10, 573-578.
Matthews, J. R., & Christophersen, E. R. (1988). Measuring and preventing
noncompliance in pediatric health care. In P. Karoly (Ed.), Handbook of child health
assessment (pp. 519-557). New York: Wiley.
McClannahan, L. E., & Krantz, P. J. (1997). In search of solutions to prompt
dependence: Teaching children with autism to use photographic activity schedules.
In D. M. Baer & E. M. Pinkston (Eds.), Environment and behavior (pp. 271-278).
Boulder, CO: Westview Press.
McGrath, M. L., Mellon, M. W., & Murphy, L. (2000). Empirically supported
treatments in pediatric psychology: Constipation and encopresis. Journal of Pediatric
Psychology, 25, 225-254.

70

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

McQuaid, F. L., & Nassau, J. H. (1999). Empirically supported treatments of diseaserelated symptoms in pediatric psychology: Asthma, diabetes, and cancer. Journal of
Pediatric Psychology, 24, 305-328.
Mellon, M. W., & McGrath, M. L. (2000). Empirically supported treatments in pediatric
psychology: Nocturnal enuresis. Journal of Pediatric Psychology, 25, 193-214.
Miller-Johnson, S., Emery, R. E., Marvin, R. S., Clarke, W. L., Lovinger, R.,
& Martin, M. (1994). Parent-child relationships and the management of insulindependent diabetes mellitus. Journal of Consulting and Clinical Psychology, 62, 603610.
Parrish, J. M. (1987). Parent compliance with medical and behavioral recommendations.
In N. A. Krasnegor, J. D. Arasteh, & M. F. Cataldo (Eds.), Child health behavior: A
behavioral pediatrics perspective (pp. 453-501). New York: Wiley.
Perrin, E. C. (1999). Commentary: Collaboration in pediatric primary care: A
pediatrician’s view. Journal of Pediatric Psychology, 24, 453-458.
Peyrot, M., McMurry, J. F., & Kruger, D. F. (1999). A biopsychosocial model of
glycemic control in diabetes: Stress, coping, and regimen adherence. Journal of
Health and Social Behavior, 40, 141-158.
Phipps, S., & DeCuir-Whalley, S. (1990). Adherence issues in pediatric bone marrow
transplantation. Journal of Pediatric Psychology, 15,459-475.
Powers, S. W. (1999). Empirically supported treatments in pediatric psychology.
Journal of Pediatric Psychology, 24, 131-146.
Rapoff, M. A. (1989). Compliance with treatment regimens for pediatric rheumatic
diseases. Arthritic Care Research, 2, 40-47.
Rapoff, M. A. (1999). Adherence to pediatric medical regimens. New York:
Kluwer/Plenum.
Rapoff, M. A., & Barnard, M. U. (1991). Compliance with pediatric medical regimens.
In J. A. Cramer & B. Spiker (Eds.), Patient compliance in medical practice and
clinical trials (pp. 73-98). New York: Raven.
Rapoff, M. A., & Christophersen, E. R. (1982). Compliance of pediatric patients with
medical regimens: A review and evaluation. In R. B. Stuart (Ed.), Adherence,
compliance, and generalization in behavioral medicine (pp. 79-124). New York:
Brunner/Mazel.

71

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Rapoff, M. A., Lindsley, C. B., & Christophersen, E. R. (1984). Improving compliance
with medical regimens: Case study with juvenile rheumatoid arthritis. Archives of
Physical Medicine and Rehabilitation, 65, 267-269.
Rapoff, M. A., Purviance, M. R., & Lindsley, C. B. (1988). Improving medication
compliance for juvenile rheumatoid arthritis and its effect on clinical outcome: A
single-subject analysis. Arthritis Care and Research, 1,12-16.
Rubin, R. R., & Peyrot, M. (2001). Psychological issues and treatments for people with
diabetes. Journal of Clinical Psychology, 57, 457-478.
Rubin R. R., Young-Hyman, D., & Peyrot, M. (1989). Parent-child responsibility and
conflict in diabetes care. Diabetes, 38 (suppl. 2), 28A (abstract).
Shabani, D. B., Katz, R. C., Wilder, D. A., & Beauchamp, K. (2002). Increasing social
initiations in children with autism: Effects of a tactile prompt. Journal of Applied
Behavior Analysis, 35, 79-83.
Silverstein, J. (1994). Diabetes: Medical issues. In R. A. Olson, L. L. Mullins, J. B.
Gillman, & J. M. Chaney (Eds.), The sourcebook of pediatric psychology (pp. 111117). Boston: Allyn & Bacon.
Taylor, B. A., & Levin, L. (1998). Teaching a student with autism to make verbal
initiations: Effects of a tactile prompt. Journal of Applied Behavior Analysis, 31,
651-654.
Thai, A., & Eisenbarth, G. (1983). Natural history of IDDM. Diabetes Reviews, 1,114.
Touchette, P. E., & Howard, J. S. (1984). Errorless learning: Reinforcement
contingencies and stimulus control transfer in delayed prompting. Journal of Applied
Behavior Analysis, 17, 175-188.
Yami, J. W., & Jay, S. M. (1984). Biobehavioral factors in juvenile rheumatoid arthritis:
Implications for research and practice. Clinical Psychology Review, 4, 543-560.
Walco, G. A., Sterlin, C. N., Conte, P. M., & Engel, R. G. (1999). Empirically
supported treatments in pediatric psychology: Disease-related pain. Journal of
Pediatric Psychology, 24, 155-167.
Wolf, E., Spencer, K. M., & Cudworth, A. G. (1983). The genetic susceptibility to type I
(insulin-dependent) diabetes: Analysis of the HLA-DR association. Diabetologica,
24, 224-230.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Wong, S. E., Seroka, P. L., Ogisi, J. (2000). Effects of a checklist on self-assessment of
blood glucose level by a memory-impaired woman with diabetes mellitus. Journal of
Applied Behavior Analysis, 33, 251-254.
Wysocki, T., Greco, P., Harris, M. A., & Bubb, J., White, N. H. (2001). Behavior
therapy for families of adolescents with diabetes: Maintenance of treatment effects.
Diabetes Care, 24, 441-446.
Wysocki, T. (1993). Associations among parent-adolescent relationships, metabolic
control, and adjustment to diabetes in adolescents. Journal of Pediatric Psychology,
18, 443-454.
Wysocki, T., Green, L., & Huxtable, K. (1989). Blood glucose monitoring by diabetic
adolescents: Compliance and metabolic control. Health Psychology, 8, 267-284.
Wysocki, T., Harris, M. A., Greco, P., Bubb, J., Danda, C. E., Harvey, L. M. et al.
(2000). Randomized, controlled trial of behavior therapy for families of adolescents
with insulin-dependent diabetes mellitus. Journal of Pediatric Psychology, 25, 23-33.
Wysocki, T., Hough, B. S., Ward, K. M., Allen, A. A., & Murgai, N. (1992). Use of
blood glucose data by families of children and adolescents with IDDM. Diabetes
Care, 15, 1041-1044.
Zimmet, P. (1983). Epidemiology of diabetes mellitus. In M. Ellenberg & H. Rifkin
(Eds.), Diabetes mellitus: Theory and practice (3rd ed., pp. 451-468). New York:
Medical Examination.

73

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix A

Enrollment Criteria
Physician Recruitment Script
Informational Flyer

74

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Enrollment Criteria
Listed below, I have outlined the enrollment criteria that will be used in this study. For
some of the criteria, I have provided a more in-depth explanation as needed. If the
patient meets the enrollment criteria, please pass out an informational flyer inviting them
to participate in this study. Potential participants that might be interested in this study
can call me at the number provided on the informational flyer.
Inclusion/Exclusion Criteria:
1. Adolescents aged 12-years-old and older will be eligible to participate in this
study.
2. Adolescents who demonstrate an average compliance rate of 50% or less than the
recommended frequency of blood glucose monitoring during the last 3 months
will be eligible for participation. Generally speaking, it is assumed that the
patient should be checking his or her blood glucose levels four times per day. To
calculate the average compliance rate during the past 3 months, please divide the
number of blood glucose checks performed by the total number recommended
(for 3 months) and multiply by 100. Patients who demonstrate an average
compliance rate of 50% or less during the last 3 months will be eligible.
3. Diagnosis of Insulin-Dependent Diabetes Mellitus (IDDM) for a duration of > 1
year.
4. At least one annual visit to the diabetes clinic during the last year.
5. No other diagnosis of any serious medical conditions
6. No documented history of any newly diagnosed psychiatric conditions during the
past 6 months.
7. No documented evidence of any serious psychiatric conditions (i.e., conduct
disorder, schizophrenia, etc.)
8. No significant mental impairment or developmental delay.
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Physician Recruitment Script
I would like to tell you about a research project that is being conducted by a
graduate student at Western Michigan University here in Kalamazoo. The purpose of this
study is to help adolescents with Type 1 Diabetes to do a better job with checking their
blood sugar levels. If you decide to participate in this study, the student investigator will
give you a Motorola™ pager to carry around with you. The student investigator will
send you pages every day to help you remember to check your blood sugar levels. You
will also be allowed to use this pager with your family and friends. You will not be able
to keep this pager after you complete the study. Here is an information flier that has the
name of the student investigator, Steve Albrecht, and his telephone number. If you are
interested in this study, you can call the student investigator to learn more about the
study.
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Informational Flyer

Research Participants Needed
A clinical researcher at WMU is seeking adolescents diagnosed
with Type 1 Diabetes to participate in a treatment study.
Are you having a difficult time remembering to check your
blood sugar levels each day? If you are having this
type of problem, this study might be for you!
If you decide to participate in this study, we will give you
a Motorola™ pager to carry around with you. The student
investigator in this study will send you pages every day to
help you to remember to check your blood sugar levels.
You will also be able to use this pager to keep in touch
with your family and friends. You will not get to keep this
pager after you are done with this study.
If you are not checking your blood sugar levels every day,
and would like to get some help, please contact
Stephen J. Albrecht by calling him at
(616) 337-6229.
When calling, please state that you are interested in the Albrecht
Study and leave your name, phone number, and the times in which
it is best to reach you by telephone.

THANK YOU!!!

All information is private and confidential

77

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix B

Initial Phone Contact Script

78

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Initial Phone Contact Script
“H ello,_________________________ . My name is Stephen J. Albrecht and I am
a graduate student from the Department of Psychology at Western Michigan University.
I recently received a message from you that you might be interested in participating in
my research study entitled, “Increasing Blood Glucose Monitoring in Adolescents with
Type 1 Diabetes: Effects of a Prompt.” I am calling you today to ask if you would be
willing to come to MSU/KCMS for a meeting with me to further discuss your
participation in this study. If you and your adolescent decide to participate, this meeting
should take 1 to 2 hours to complete. During this meeting, I will ask you and your
teenager to read and sign a consent form and if you decide to participate, to complete
several questionnaires. I will also provide your teenager with an electronic pager and
will show them how to use it during this meeting. I will be available during this meeting
to answer any questions or concerns that you might have regarding this study. Would
you like to set up an appointment?”
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Demographic Questionnaire - Adolescent Version
Directions: Please answer the following questions by checking the box, filling in the
blank, or circling the answer.
1. What is your present age?
01
02
03
04
05
06

12 years
13 years
14 years
15 years
16 years
17 years

2. What is your gender?
01
02

Male
Female

3. What best describes your race/ethnicity?
01
02
03
04
05
06

Asian/Pacific Islander
African American
Hispanic/Latino
Native American
White
Other

4. Are you currently going to school?
01
02

Yes
No

5. What is the name of your school?________________________________
What is your present grade level?
01
02
03
04
05
06
07

6th Grade
7th Grade
8th Grade
9th Grade
10th Grade
11th Grade
12th Grade

How long have you had diabetes?
01
02
03
04
05
06

1 to 3 Years
4 to 7 Years
8 to 11 Years
12 to 15 Years
16 to 19 Years
19 to 21 Years
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8. Have you had any type of conflict or arguments with your parents about managing
your diabetes?
01
02

Yes
No

9. If you answered “Yes” to question # 8 above, what did you argue about? Please
circle all that apply.
01
02
03
04
05
06
07
08
09

Testing urine for Ketones
Checking blood sugar levels
Recording blood sugar levels in log book
Administering Insulin shots
Eating the proper foods
Exercising on a regular basis
Making doctor appointments
Remembering to take meter to school
Other

How many times do you usually test your blood sugar each week?
01
02
03
04
05
06
07
08
09

1-5 times
6-10 times
11-15 times
16-20 times
21-25 times
26-30 times
31-35 times
36-40 times
41 or more times

When do you most often forget to test your blood sugar levels? Please circle all that
apply.
01
02
03
04
05
06
07

At school
Before breakfast
Before lunch
Before dinner
Before bedtime
When I feel fine
I forgot my equipment

08
09
10
11
12
13
14

When on a vacation or weekend trip
At an evening party or dance
When feeling sick
While hanging out with friends
During the summer months
When I feel embarrassed
When I do not want to know my level

12. Do you ever need reminders from your parents to test your blood sugar levels?
01
02

Yes
No
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13. If you answered “Yes” to question # 12 above, how many times during the last week
did your parents remind you to check your blood sugar levels?
01
02
03
04
05
06
07
08
09
10
11

1-2 times
3-4 times
5-6 times
7-8 times
9-10 times
11-12 times
13-14 times
15-16 times
17-18 times
19-20 times
21 or more times

14. Do you ever need reminders from your parents to do your Insulin shots?
01
02

Yes
No

15. If you answered “Yes” to question # 14 above, how many times during the last week
did your parents remind you to do your Insulin shots?
01
02
03
04
05
06
07
08
09
10
11

1-2 times
3-4 times
5-6 times
7-8 times
9-10 times
11-12 times
13-14 times
15-16 times
17-18 times
19-20 times
21 or more times

16. Do you ever get mad or angry with your parents when they tell you or remind you to
complete a diabetes-related task?
01
02

Yes
No

17. Have you ever not checked your blood sugar levels when you are mad or angry with
your parents?
01
02

Yes
No
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18. On the lines below, please write down the times when you usually eat breakfast,
lunch, and dinner, and your bedtime.
01
02
03
04

Breakfast
Lunch
Dinner
Bedtime

Time:
Time:
Time:
Time:

_____
_____
_____
_____

19. Are you currently seeing a counselor, therapist, psychologist, or psychiatrist for
personal concerns?
01
02

Yes
No

20. If you answered “Yes” to question # 19 above, please indicate which personal
concerns led you to seek counseling/therapy at this time?
01
02
03
04
05
06
07
08

Depression
Anxiety
Traumatic experience
Relationship problems
Academic problems
Obsessive/Compulsive disorder
Eating disorder
Alcohol or drug problems

09
10
11
12
13
14
15
16

Manic depressive disorder
Schizophrenia
Anger control problems
Learning disability
Panic disorder
Agoraphobia/Other phobias
Career development
Other:

21. Have you ever attended a summer camp or training program to help you better
manage your diabetes?
01
02

Yes
No

22. Do you have a computer with Internet access in your house?
01
02

Yes
No
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Demographic Questionnaire - Parent Version
Directions: Please answer the following questions by filling in the blank or circling the
answer.
1. What is your present age?___________________
2. What is your gender?
01
02

Male
Female

3. What best describes your race/ethnicity?
01
02
03
04
05
06

Asian/Pacific Islander
African American
Hispanic/Latino
Native American
White
Other

4. Did you graduate from high school?
01
02

Yes
No

5. How many years of school have you completed after college?
01
02
03
04
05
06
07

0 years
1 year
2 years
3 years
4 years
5 years
6 or more years

6. What educational degrees do you ho ld ?_______________________________
7. Are you currently employed?
01
02

Yes
No

8. Are you working full-time or part-time?
01
02

Full-Time
Part-Time

9. If you answered “Yes” to question # 8 above, what kind of work do you do?
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10. What is your current family yearly income, before taxes?
01
02
03
04
05
06
07
08
09

$15,000 or less
$15,001 - $25,000
$25,001 - $35,000
$35,001 - $50,000
$50,001 - $65,000
$65,001 - $75,000
$75,001 - $85,000
$85,001 - $100,000
Over $100,000

Are you currently married?
01
02

Yes
No

12. Have you been married before?
01
02

Yes
No

13. Are you currently living with your spouse?
01
02

Yes
No

14. How many years has your son or daughter had diabetes?
01
02
03
04
05
06

1 to 3 Years
4 to 7 Years
8 to 11 Years
12 to 15 Years
16 to 19 Years
19 to 21 Years

15. Have you had any type of conflict or arguments with your son or daughter about the
management of his or her diabetes?
01
02

Yes
No

16. If you answered “Yes” to question # 1 6 above, what did you argue about? Please
circle all that apply.
01
02
03
04
05
06
07
08

Testing urine for Ketones
Testing blood sugar levels
Recording blood sugar levels in log book
Administering Insulin shots
Eating the proper foods
Exercising on a regular basis
Making doctor appointments
Remembering to take meter to school
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17. How many times does your son or daughter test his or her blood sugar each week?
01
02
03
04
05
06
07
08
09

1-5 times
6-10 times
11-15 times
16-20 times
21-25 times
26-30 times
31-35 times
36-40 times
41 or more times

18. Does your son or daughter ever forget to check his or her blood sugar levels?
01
02

Yes
No

19. If you answered “Yes” to question # 19 above, how many times does your son or
daughter forget to check his or her blood sugar levels each week?
01
02
03
04
05
06

1-5 times
6-10 times
11-15 times
16-20 times
21-25 times
26 or more times

When does your son or daughter most often forget to test his or her blood sugar
levels? Please circle all that apply.
01
02
03
04
05

At school
Before breakfast
Before lunch
Before dinner
Before bedtime

06
07
08
09
10

When on a vacation or weekend trip
When at an evening party or dance
When feeling sick
While hanging out with friends
During the summer months

21. Do you ever have to remind your son or daughter to check his or her blood sugar
levels?
01
02

Yes
No

22. If you answered “Yes” to question # 22 above, how many times during the week do
you have to remind your son or daughter to check his or her blood sugar levels?
01
02
03
04
05
06
07
08

1-2 times
3-4 times
5-6 times
7-8 times
9-10 times
11-18 times
19-20 times
21 or more times
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23. When does your son or daughter most often forget to check his or her blood sugar
levels? Please circle all that apply.
01
02
03
04
05

At school
Before breakfast
Before lunch
Before dinner
Before bedtime

06
07
08
09
10

When on a vacation or weekend trip
When I go to evening part or dance
When I am feeling sick
While hanging out with friends
During the summer months

24. Have you ever had to remind your son or daughter to take his or her Insulin shots?
01
02

Yes
No

25. If you answered “Yes” to question # 25 above, how many times each week do you
have to remind your son or daughter to take his or her Insulin shots?
01
02
03
04
05
06
07
08
09
10
11

1-2 times
3-4 times
5-6 times
7-8 times
9-10 times
11-12 times
13-14 times
15-16 times
17-18 times
19-20 times
21 or more times

26. Has your teenager ever been made or angry with you after you tell or remind him or
her to complete a diabetes-related task?
01
02

Yes
No

27. Do you think that your teenager has ever purposely not check his or her blood sugar
levels when they are mad or angry with you?
01
02

Yes
No

28. On the lines below, please write down the times when your son or daughter usually
eats breakfast, lunch, and dinner, and bedtime.
01
02
03
04

Breakfast
Lunch
Dinner
Bedtime

Time:
Time:
Time:
Time:
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29. Is your son or daughter currently seeing a counselor, therapist, psychologist, or
psychiatrist for personal concerns?
01
02

Yes
No

30. If you answered “Yes” to question # 30 above, please indicate which personal
concerns led your son or daughter to seek counseling/therapy at this time?
01
02
03
04
05
06
07
08

Depression
Anxiety
Traumatic experience
Relationship problems
Academic problems
Obsessive/Compulsive disorder
Eating disorder
Alcohol or drug problems

09
10
11
12
13
14
15
16

Manic depressive disorder
Schizophrenia
Anger control problems
Learning disability
Panic disorder
Agoraphobia/Other phobias
Career development
Other:

31. Has your teenager ever been diagnosed with a psychological disorder?
01
02

Yes
No

32. If you answered “Yes” to question #32 above, what was your son or daughter
diagnosed w ith ?____________________________________________________________
33. Have your son or daughter ever attended a summer camp or training program to help
him or her to better manage the diabetes?
01
02

Yes
No

34. Has your teenager ever participated in a summer camp or some other training
program to help him or her manage the diabetes?
01
02

Yes
No

35. On the lines below, please indicated several good days and times for when the student
investigator can get a hold of you by telephone each week.
Day:
Day:
Day:
Day:

_____________Time:
_____________Time:
_____________Time:
_____________ Time:

______________
______________
______________
______________

36. Do you own a computer with Internet access?
01
02

Yes
No
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SCI
Instructions: Please rate each of the items according to HOW WELL YOU FOLLOWED
YOUR PRESCRIBED REGIMEN FOR DIABETES CARE in the past month. Then,
using the rating scale below, please carefully read and answer each statement. If a
statement does not apply to you, then rate it as “Not Applicable [NA].”
Ratings:
1 = Never
2 = Sometimes (about 25% of the time)
3 = About 50% of the time
4 = Often (about 75% of the time)
5 = Always (100% of the time)
NA = Cannot rate this item (Not Applicable)
In the past month, how well have you followed the recommendations for:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

Glucose Testing
Glucose Recording
Ketone Testing
Administering Correct Insulin Dose
Administering Insulin at Right Time
Adjusting Insulin Intake Based on
Blood Glucose Values
Eating the Proper Foods; Sticking to
the Meal Plan
Eating Meals on Time
Eating Regular Snacks
Carrying Quick-Acting Sugar to
Treat Reactions
Coming in for Appointments
Wearing a Medic Alert ID
Exercising Regularly
Exercising Strenuously

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

NA
NA
NA
NA
NA

1

2

3

4

5

NA

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

NA
NA
NA

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

NA
NA
NA
NA
NA
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TADS - Adolescent
Instructions: This is a survey about how you have reacted to diabetes during the past
month. Below you will read some statements, which may describe your behavior toward
diabetes during that time. Next to each statement, please circle the number which best
describes you during that time.
How often did you:
Never

Rarely

Sometimes

Usually

Always

1. Eat exactly what was on the meal
plan?

1

2

3

4

5

2. Eat meals on a strict schedule?

1

2

3

4

5

3. Pass up candy or sweets when they
were offered?

1

2

3

4

5

4. Eat snacks as instructed?

1

2

3

4

5

5. Draw up insulin doses very carefully?

1

2

3

4

5

6. Take insulin about 30 minutes before
meals?

1

2

3

4

5

7. Use many different places for shots?

1

2

3

4

5

8. Test blood sugar at least twice daily?

1

2

3

4

5

9. Write down every blood sugar test
result immediately in a log book?

1

2

3

4

5

10. Do blood sugar test just before
taking insulin shots?

1

2

3

4

5

11. Tell the truth to parents and doctors
about diet, test results, etc.?

1

2

3

4

5

12. Enjoy learning about diabetes?

1

2

3

4

5
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TADS - Adolescent
Instructions: This is a survey about how you have reacted to diabetes during the past
month. Below you will read some statements, which may describe your behavior toward
diabetes during that time. Next to each statement, please circle the number which best
describes you during that time.
Never

Rarely

Sometimes

13. Accept being different from others?

14. Express appreciation to doctors and '
nurses?
15. Feel there is hope for the future
despite having diabetes?
16. Feel confident about taking shots,
doing blood sugar tests, and eating a
special diet?
17. Enjoy being around others with
diabetes?
18. W ear diabetic identification?

19. Tell friends about diabetes and its
treatment
20. Explain diabetes and its treatment to
teachers, coaches, and other parents,
etc.?
21. Seek help quickly when blood sugar
got too high or there were ketones in
your urine?
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Usually

Always

TADS - Parent
Instructions: This is a survey about how your son or daughter has reacted to diabetes
during the past month. Below you will read some statements, which may describe your
son’s or daughter’s behavior toward diabetes during that time. Next to each statement,
please circle the number which best describes your son or daughter during that time.
How often did your son or daughter:
Never

Rarely

Sometimes

Usually

Always

1. Eat exactly what was on the meal
plan?

2

3

4

5

2. Eat meals on a strict schedule?

2

3

4

5

3. Pass up candy or sweets when they
were offered?

2

3

4

5

4. Eat snacks as instructed?

2

3

4

5

5. Draw up insulin doses very carefully?

2

3

4

5

6. Take insulin about 30 minutes before
meals?

2

3

4

5

7. Use many different places for shots?

2

3

4

5

8. Test blood sugar at least twice daily?

2

3

4

5

9. Write down every blood sugar test
result immediately in a log book?

2

3

4

5

10. Do blood sugar test just before
taking insulin shots?

2

3

4

5

11. Tell the truth to parents and doctors
about diet, test results, etc.?

2

3

4

5

12. Enjoy learning about diabetes?

2

3

4

5
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TADS - Parent
Instructions: This is a survey about how your son or daughter has reacted to diabetes
during the past month. Below you will read some statements, which may describe your
son’s or daughter’s behavior toward diabetes during that time. Next to each statement,
please circle the number which best describes your son or daughter during that time.
Never

Rarely

Sometimes

13. Accept being different from others?

14. Express appreciation to doctors and
nurses?
15. Feel there is hope for the future
despite having diabetes?
16. Feel confident about taking shots,
doing blood sugar tests, and eating a
special diet?
17. Enjoy being around others with
diabetes?
18. W ear diabetic identification?

19. Tell friends about diabetes and its
treatment
20. Explain diabetes and its treatment to
teachers, coaches, and other parents,
etc.?
21. Seek help quickly when blood sugar
got too high or there were ketones in
your urine?
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Usually

Always

Diabetes Responsibility Scale (DRC)
Child
all the
time

Child
most
of the
time

Parent
and
child
half

Parent
most
of the
time

Parent
all the
time

1. Who remembers what time to give your
child’s insulin?

1

2

3

4

5

2. Who measures/draws up the insulin dose?

1

2

3

4

5

3. Who give the injections?

1

2

3

4

5

4. Who checks the blood sugars?

1

2

3

4

5

5. Who keeps track of blood/urine records?

1

2

3

4

5

6. Who takes care of hypos?

1

2

3

4

5

7. Who decides what to eat at meals and
snacks?

1

2

3

4

5

8. Who decides what to eat (away from home)
at movies or birthday parties?

1

2

3

4

5

9. Who talks to the diabetes teams about
diabetes care?

1

2

3

4

5

10. Who talks to adults about your child’s
diabetes (like teachers or the principal)?

1

2

3

4

5

11. Who talk to your child’s friends about
diabetes?

1

2

3

4

5

12. Who makes sure your child has
insulin/syringes/supplies?

1

2

3

4

5

13. Who decides when your child exercises?

1

2

3

4

5

14. Who decides which people know your
child has diabetes?

1

2

3

4

5

For each of the following parts of your child’s
diabetes care, circle the number that best
describes the way you handle things at home.
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Diabetes Responsibility Scale (DRC)
Never

Some
times

Half
the
time

Frequ
ently

All
the
time

15. Who remembers what time to give your
child’s insulin?

1

2

3

4

5

16. Who measures/draws up the insulin dose?

1

2

3

4

5

17. Who give the injections?

1

2

3

4

5

18. Who checks the blood sugars?

1

2

3

4

5

19. Who keeps track of blood/urine records?

1

2

3

4

5

20. Who takes care of hypos?

1

2

3

4

5

21. Who decides what to eat at meals and
snacks?

1

2

3

4

5

22. Who decides what to eat (away from
home) at movies or birthday parties?

1

2

3

4

5

23. Who talks to the diabetes teams about
diabetes care?

1

2

3

4

5

24. Who talks to adults about your child’s
diabetes (like teachers or the principal)?

1

2

3

4

5

26. Who talk to your child’s friends about
diabetes?

1

2

3

4

5

27. Who makes sure your child has
insulin/syringes/supplies ?

1

2

3

4

5

28. Who decides when your child exercises?

1

2

3

4

5

29. Who decides which people know your
child has diabetes?

1

2

3

4

5

For each of the following parts of your child’s
diabetes care, circle the number which best
describes how much you argue/hassle with
your child about it.
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Appendix D

Informed Consent Documents

97

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Parent Consent for Own Participation and for
Son or Daughter To Participate
An Office-Based Intervention Designed to Improve Blood Glucose
Monitoring in Adolescents With Insulin-Dependent Diabetes Mellitus
Principal Investigator: Amy E. Naugle, Ph.D.
Student Investigator: Stephen J. Albrecht, M.A.
Western Michigan University
Department of Psychology
You and your teenager have been invited to participate in a research study entitled
“An Office-Based Intervention To Improve Blood Glucose Monitoring in Adolescents
with Insulin-Dependent Diabetes Mellitus.” This study will help us learn more about a
treatment designed to increase the number of times that adolescents with diabetes check
their blood sugar levels. The goal of this study is to help your adolescent do a better job
with monitoring your blood sugar levels. This study will also look at how well this
treatment can be used in the diabetes clinic where your teenager is currently receiving his
or her medical services. This study is Stephen Albrecht’s dissertation project.
W hat is involved? Your decision to participate and your permission for your

teenager to participate in this project means that both you and your teenager will be asked
to spend about 90 minutes in a meeting with the student investigator at Michigan State
University/Kalamazoo Center for Medical Studies (MSU/KCMS). During this meeting,
you and your teenager will be asked to complete several questionnaires. You and your
teenager will be asked to share some personal information on these forms, such as age,
racial identity, and level of education. These questionnaires will also ask questions about
whether you have had any conflicts or arguments with each other about his or her
diabetes. You will also be asked to report the number of times that your teenager usually
checks his or her blood sugars and completes his or her Insulin injections each week. It
will take you and your teenager about 30 to 45 minutes to complete these questionnaires.
If you and your adolescent agree to participate in this study, your teenager will be
asked to participate in a 7-week paging treatment. You and your teenager will not be
required to make any additional office-based visits during this treatment. If your teenager
decides to participate, he or she will be provided with one electronic pager. Your
teenager will not be able to keep this pager after they have completed the study. Your
teenager will be provided with the pager number and will be allowed to give this number
out to family and friends at no cost during the treatment period. Your teenager will be
asked to carry this pager with them at all times, including those times when they are away
from home or in school. Your teenager will be provided with a letter so that she or he has
formal permission to use this pager while attending school. Before your teenager starts
receiving pages, the student investigator will call your teenager every three days to find
out how many times that they have been checking their blood sugar levels each day.
When the student investigator calls your teenager, he or she will be asked to look at their
reflectance meter to determine how many times that they checked their blood sugar
levels. The student investigator will contact your teenager to let him or her know when
their pager will be activated. Your teenager will start receiving the pages one day after
the pager has been activated. During the treatment, the student investigator will send
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several pages each day for a period of 7-weeks to remind your teenager to check his or
her blood sugar levels. Your teenager will receive 4 pages per day for the first four weeks
of the treatment, followed by 3 pages per day in Week 5, 2 pages per day in Week 6, and
1 page per day in Week 7.
After your teenager starts receiving pages, the student investigator will complete
one 15-minute telephone call with your teenager at the end of each week to gather
information on how well they have been following their diet, exercising, and completing
their Insulin injections. During these telephone contacts, the student investigator will
also ask your teenager to report how many times that they are checking their blood sugar
levels each week.
At the end of the 7-week paging treatment, the student investigator will then
contact you and your teenager by telephone at 3-months and 6-months following the
completion of the treatment. During these one-time telephone contacts, you and your
teenager will also be asked to complete several questionnaires over the phone. These are
the same questionnaires that you will complete during today’s meeting. Since you will
not have a copy of these questionnaires, the student investigator will read the questions to
you and your teenager. The student investigator will contact you and your teenager oneweek before to let you that this information will be collected the following week.
P oten tial Benefits You and your teenager may benefit from participating in this
study in several ways. The treatment that will be used in this study may increase the
number of blood sugar checks that your teenager completes each week. By increasing
the number of blood sugar checks, your teenager may obtain better control of his or her
diabetes condition, which may help prevent the development of potentially serious
medical problems. Another possible benefit may be that it helps your teenager to develop
more independence and take more responsibility in managing his or her diabetes. Your
teenager will also be provided with a free paging service and will be able to stay in
contact with you, other family members, and friends by using the electronic pagers. This
study may also help in the development of cost-effective interventions that can be used in
the context of a medical setting. And finally, other children and adolescents with
diabetes may benefit in the future from the knowledge that is gained from this research
study.
Risks o f P articipatin g in Study As in all research, there may be unforeseen risks to
the participant. If an accidental injury occurs, appropriate emergency measures will be
taken; however, no compensation or treatment will be made available to your adolescent
except otherwise specified in the consent form. There are minimal risks for you and your
teenager in this study. The only risks anticipated for you and your teenager are the minor
discomforts and inconveniences that may be experienced when asked to fill out
questionnaires or participate in weekly telephone contacts. Another possible
risk/inconvenience involves the time commitment required for the office-based visit at
MSU/KCMS. This may pose a time commitment inconvenience and/or transportation
difficulty. You and your teenager may also experience discomfort when asked to
disclose personal information about yourselves on the questionnaires. Your son or
daughter may also get tired of checking his or her blood sugar levels and talking to the
student investigator on the telephone at the end of each week. Your son or daughter may
also experience some distress or minor discomforts if school staff asks them why they are
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carrying a pager with them on school property. We anticipate that this risk will be
minimal. The student investigator in this study will provide a letter for your son and
daughter in the event that school staff asks them why they have a pager in school. The
student investigator and your physician at MSU/KCMS will sign this letter. Given that
your adolescent will be allowed to use the pager for personal purposes, there is a risk that
he/she will abuse or misuse their pager privileges. Such misuse may result in adverse
consequences (e.g., getting in trouble at school). You have the right to implement
consequences for any misuse. One additional risk is that you may begin to rely on the
pager to remind your adolescent and therefore decrease how often you remind your
teenager. This is not necessarily a bad outcome, if your teenager is able to increase their
blood-glucose monitoring due to the pager intervention. However, it is possible that by
decreasing your reminders, your teenager will decrease their blood-glucose monitoring.
We are not asking you to change anything about your behavior or how you remind your
teenager.
In the event that your teenager needs immediate medical attention for his or her
diabetes, we will ask that you respond as you ordinarily would in an emergency situation
by immediately seeking medical attention from your hospital and/or contacting your
physician. If your adolescent is significantly distressed and it becomes clear that
individual therapy may be more immediately useful, an appropriate referral to a
competent mental health professional will be made.
C onfidentiality o f D a ta You and your teenager’s responses and performance in
this project will remain strictly confidential. That means that you and your teenager’s
name will not appear on any research questionnaires or forms completed during this
study. No other person other than you and your teenager will have access to the pager
number, unless your teenager decides to give out his or her number to other family
members and friends. All forms and computer files with information regarding you and
your teenager’s performance will be coded with a unique number in order to ensure
confidentiality. All information will be labeled with this research number and stored in a
locked file cabinet in a laboratory at Western Michigan University. The student
investigator will keep a separate master list with the names of the participants and the
corresponding code numbers. Once the data are collected and analyzed, the master list
will be destroyed, thus rendering you and your adolescent’s information anonymous. All
other questionnaires and forms will be saved for at least three years in a locked file in the
primary investigator’s laboratory. Information collected in this study will be disclosed in
professional journals so as to assist clinicians, physicians, and other researchers in their
understanding of how to improve the management of diabetes in adolescent populations.
Information presented in such publications will be anonymous so as to ensure you and
your teenager’s confidentiality.
P articipation is Voluntary You and your teenager’s participation in this study is

completely voluntary. You and your teenager may withdraw from this study at any time
without any negative effect on services provided to you or your teenager. There will be
no penalty if you and your teenager do not wish to be involved in this study, and you may
withdraw at any time during the study and refuse to answer any of the questions. Your
decision on whether or not to allow you and your teenager to participate in this study will
not jeopardize your future relations with Western Michigan University or the medical
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services provided at Michigan State University/Kalamazoo Center for Medical Studies
(MSU/KCMS).
Q uestions? We invite you to ask any questions you may have. If you have any
additional questions or concerns about this study, please feel free to contact Stephen
Albrecht at 387-4485 or Dr. Amy Naugle at 387-4726. We will be happy to answer any
of your questions. You may also contact the Chair of the Human Subjects Institutional
Review Board (387-8293) or the Vice President for Research (387-8298) with any
questions or problems that arise during this study. You will be given a copy of this form
to keep for your records.

This consent document has been approved for use for one year by the Human
Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and the
signature of the board chair in the upper right comer of all pages. Participants, including
parents or legal guardians, should not sign this document if the comer of all pages does
not show a stamped date and signature.
Your signature below indicates that you, as parent or legal guardian, can and do
give your perm ission________________________________ (child’s name) to
participate in this study.
Time:_____________________

Date:_____________________

Signature of Parent or Legal Guardian

Date

Teenager’s Name (Please Print Name)

Date

Signature of Student Investigator Obtaining Permission

Date

You are also making a decision as to whether or not you would like to participate in
this study. Your signature below indicates that you have read the information
provided above and have decided to provide consent to participate in this study.
Date:________________________________________ Time: _________________ _

Signature of Parent or Legal Guardian

Date

Signature of Student Investigator Obtaining Permission

Date
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Assent for Teenagers
An Office-Based Intervention Designed to Improve Blood Glucose
Monitoring in Adolescents With Insulin-Dependent Diabetes Mellitus
Principal Investigator: Amy E. Naugle, Ph.D.
Research Associate: Stephen J. Albrecht, M.A.
Western Michigan University
Department of Psychology
You and your parent(s) have been invited to participate in a research study
entitled “An Office-Based Intervention To Improve Blood Glucose Monitoring in
Adolescents with Insulin-Dependent Diabetes Mellitus.” This study will help us learn
more about a treatment designed to increase the number of times that adolescents with
diabetes check their blood sugar levels. The goal of this study is to help you do a better
job with monitoring your blood sugar levels. This study will also look at how well this
treatment can be used in the diabetes clinic where you are currently receiving your
medical services. This study is Stephen Albrecht’s dissertation project.
What is involved? If you agree to participate in this study, you and your parent(s)
will be asked to spend about 90 minutes in a meeting with the student investigator at
Michigan State University/Kalamazoo Center for Medical Studies (MSU/KCMS).
During this meeting, you and your parent(s) will be asked to complete several
questionnaires. You and your parents(s) will be asked to share some personal information
on these forms, such as age, racial identity, and level of education. These questionnaires
will also ask questions about whether you have had any conflicts or arguments with your
parent(s) about your diabetes. You and your parent(s)will also be asked to report the
number of times that you check your blood sugar levels and complete your Insulin
injections each week. It will take you about 30 to 45 minutes to complete these
questionnaires.

If you decide to participate, you will be asked to participate in a 7-week paging
treatment. You will not be required to make any additional office-based visits during this
treatment. If you decide to participate, you will be provided with one electronic pager.
You will not be able to keep this pager after you are finished with this study. You will be
asked to carry this pager with you at all times, including those times when you are away
from home or in school. You will be able to give out the pager number to your family
and friends and may use the pager at no cost to you during the treatment period. You will
be provided with a letter so that you can have permission to use this pager while going to
school.
Before you start receiving pages on your pager, the student investigator will call
you every three days to see how you are doing with your diabetes. The student
investigator will ask you to report the number of blood sugar tests that you performed by
looking at your reflectance meter. After a period of time, the student investigator of this
study will contact you to let you know when your pager will start receiving pages. The
student investigator will send several pages to you each day for a total of 7 weeks. These
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pages will help you to remember to check your blood sugar levels each day. You will
receive 4 pages per day for the first four weeks of the treatment, followed by 3 pages per
day in Week 5, 2 pages per day in Week 6, and 1 page per day in Week 7. Since the
pages will help you to remember to check your blood sugar levels, your parents will be
asked to not remind you as much to check your blood sugar levels.
After you start receiving pages and throughout the 7-week treatment, the student
investigator will complete one 15-minute telephone call with you at the end of each week
to gather information on how well you have been following your diet, exercising, and
completing your Insulin shots. The student investigator will also ask you to report how
many times you have checked your blood sugar levels each day. You will determine how
many blood sugar tests you have performed by looking at your reflectance meter.
At the end of the 7 weeks, the student investigator will then contact you and your
parent(s) by telephone at 3-months and 6-months after you complete the treatment.
During these one-time telephone calls, you will be asked to share the same information
that was collected from you during the treatment. You will be asked to complete several
questionnaires over the phone. These are the same questionnaires that you will complete
during today’s meeting. Since you will not have a copy of these questionnaires, the
student investigator will read the questions to you. The student investigator will contact
you one-week before this telephone call to help remind you.
P otential Benefits You may benefit from participating in this study in several
ways. If you decide to participate in this study, it may help you to do a better job with
checking your blood sugar levels each day. This will help you to better manage your
blood sugar levels, which may help you from having other medical problems. This study
may also help you to become more independent from your parents in managing your
diabetes. You will also be provided with a free paging service during this study. This
will allow you to stay in contact with your friends and family. This study may also be
helpful to your doctors in providing similar interventions to other adolescents. Also,
other adolescents with diabetes may benefit in the future from the knowledge that is
gained from this research study.

Risks o f P articipating in Study. As in all research, there may be unforeseen risks

to the participant. If an accidental injury occurs, appropriate emergency measures will be
taken; however, no compensation or treatment will be made available to you except
otherwise specified in the consent form. There are minimal risks for you in this study.
You might feel uncomfortable when you fill out the questionnaires or complete the
weekly telephone contacts. Also, the time it takes to complete the phone calls might be
inconvenient for you. You may also get tired of checking your blood sugar levels and
talking to the student investigator on the telephone at the end of each week. If school
staff asks you why you are carrying a pager with you on school property, you might feel
embarrassed or uncomfortable. The student investigator in this study will provide a letter
for you in case school staff asks you why you have a pager in school. The student
investigator and your physician at MSU/KCMS will sign this letter. Given that you will
be allowed to use the pager for personal purposes, if you choose to abuse or misuse your
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pager privileges, there may be negative consequences for you for doing so (e.g., getting
in trouble at school or with your parents). If you do abuse these privileges, your parent(s)
has the right to stop your participation in the study and to return the pager to us. One
additional risk is that your parents may stop reminding you so often about checking your
blood-glucose levels. This is not necessarily a bad outcome, if you are able to increase
their blood-glucose monitoring due to the pager intervention. However, it is possible that
by decreasing their reminders, you forget to check your blood-glucose levels or decrease
your blood-glucose monitoring.
If you are feeling sick, you will be asked to tell your parents, call your doctor, or
go to the hospital to get medical attention. If you become distressed or upset and would
like to participate in therapy or counseling, you will be asked to tell your parents and a
referral to a mental health professional will be made.
C onfidentiality o f D ata. The information you provide and your answers on the
questionnaires will be kept confidential. No one other than you and your parent(s) will
be able to access this information. Your name will not be on any of the questionnaires or
forms that you complete in this study. No one other than you and your parent(s) will
have access to your pager number, unless you decide to give out your pager number to
family and friends. The student investigator will use a code number on all questionnaires
and forms. The student investigator will keep a list of names and code numbers locked up
in a room. This list will be destroyed when you are done with the study. You will also
not have to tell any of your friends why you are carrying a pager.

P articipation is Voluntary Your participation in this study is completely voluntary.

Even if you agree to participate in this study by signing this form, you can change your
mind at any time and stop participating in this study. Your decision on whether or not to
participate in this study will not jeopardize your future relations with Western Michigan
University or the medical services provided at Michigan State University/Kalamazoo
Center for Medical Studies (MSU/KCMS). You may also refuse to answer any of the
questions. If you decide to stop, the doctors and other workers at the diabetes clinic will
also not get mad at you.

Q uestions? We will be happy to answer any of your questions. If you have any

additional questions or concerns about this study, you may call either Stephen Albrecht at
387-4485 or Dr. Amy Naugle at 387-4726. You may also contact the Chair of the
Human Subjects Institutional Review Board (387-8293) or the Vice President for
Research (387-8298) with any questions or problems that arise during this study. You
will be given a copy of this form to keep for your records.
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This consent document has been approved for use for one year by the Human
Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and the
signature of the board chair in the upper right comer of all pages. Participants, including
parents or legal guardians, should not sign this document if the comer does not show a
stamped date and signature.

YOU ARE MAKING A DECISION WHETHER OR NOT YOU WOULD LIKE
TO PARTICIPATE IN THIS STUDY. YOUR SIGNATURE BELOW INDICATES
THAT YOU HAVE READ THIS FORM, UNDERSTAND THE STUDY, AND
HAVE DECIDED TO PARTICIPATE IN THIS STUDY.
Date___________________________________Time______________

Please print name here

Date

Sign name here

Date

Signature of Student Investigator Obtaining Assent

Date
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Consent for Own Participation
An Office-Based Intervention Designed to Improve Blood Glucose
Monitoring in Adolescents With Insulin-Dependent Diabetes Mellitus
Principal Investigator: Amy E. Naugle, Ph.D.
Research Associate: Stephen J. Albrecht, M.A.
Western Michigan University
Department of Psychology
You and your parent(s) have invited to participate in a research study entitled “An
Office-Based Intervention To Improve Blood Glucose Monitoring in Adolescents with
Insulin-Dependent Diabetes Mellitus.” This study will help us learn more about a
treatment designed to increase the number of times that individuals with diabetes check
their blood sugar levels. The goal of this study is to help you do a better job with
monitoring your blood sugar levels. This study will also look at how well this treatment
can be used in the diabetes clinic where you are currently receiving your medical
services. This study is Stephen Albrecht’s dissertation project.

W hat is involved? If you agree to participate in this study, you and your parent(s)
will be asked to spend about 90 minutes in a meeting with the student investigator at
Michigan State University/Kalamazoo Center for Medical Studies (MSU/KCMS).
During this meeting, you and your parent(s) will be asked to complete several
questionnaires. You and your parents(s) will be asked to share some personal information
on these forms, such as age, racial identity, and level of education. These questionnaires
will also ask questions about whether you have had any conflicts or arguments with your
parent(s) about your diabetes. You and your parent(s) will also be asked to report the
number of times that you check your blood sugar levels and complete your Insulin
injections each week. It will take you about 30 to 45 minutes to complete these
questionnaires.

If you decide to participate, you will be asked to participate in a 7-week paging
treatment. You will not be required to make any additional office-based visits during this
treatment. If you decide to participate, you will be provided with one electronic pager.
You will not be able to keep this pager after you are finished with this study. You will be
asked to carry this pager with you at all times, including those times when you are away
from home or in school. You will be able to give out the pager number to your family
and friends and may use the pager at no cost to you during the treatment period. You will
be provided with a letter so that you can have permission to use this pager while going to
school.
Before you start receiving pages on your pager, the student investigator will call
you every three days to see how you are doing with your diabetes. The student
investigator will ask you to report the number of blood sugar tests that you performed by
looking at your reflectance meter. After a period of time, the student investigator of this
study will contact you to let you know when your pager will start receiving pages. The
student investigator will send several pages to you each day for a total of 7 weeks. These

106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

pages will help you to remember to check your blood sugar levels each day. You will
receive 4 pages per day for the first four weeks of the treatment, followed by 3 pages per
day in Week 5, 2 pages per day in Week 6, and 1 page per day in Week 7. Since the
pages will help you to remember to check your blood sugar levels, your parents will be
asked to not remind you as much to check your blood sugar levels.
After you start receiving pages and throughout the 7-week treatment, the student
investigator will complete one 15-minute telephone call with you at the end of each week
to gather information on how well you have been following your diet, exercising, and
completing your Insulin shots. The student investigator will also ask you to report how
many times you have checked your blood sugar levels each day. You will determine how
many blood sugar tests you have performed by looking at your reflectance meter.
At the end of the 7 weeks, the student investigator will then contact you and your
parent(s) by telephone at 3-months and 6-months after you complete the treatment.
During these one-time telephone calls, you will be asked to share the same information
that was collected from you during the treatment. You will be asked to complete several
questionnaires over the phone. These are the same questionnaires that you will complete
during today’s meeting. Since you will not have a copy of these questionnaires, the
student investigator will read the questions to you. The student investigator will contact
you one-week before this telephone call to help remind you.

P oten tial Benefits You may benefit from participating in this study in several
ways. If you decide to participate in this study, it may help you to do a better job with
checking your blood sugar levels each day. This will help you to better manage your
blood sugar levels, which may help you from having other medical problems. This study
may also help you to become more independent from your parents in managing your
diabetes. You will also be provided with a free paging service during this study. This
will allow you to stay in contact with your friends and family. This study may also be
helpful to your doctors in providing similar interventions to other adolescents. Also,
other adolescents with diabetes may benefit in the future from the knowledge that is
gained from this research study.

Risks o f P articipatin g in Study As in all research, there may be unforeseen risks
to the participant. If an accidental injury occurs, appropriate emergency measures will be
taken; however, no compensation or treatment will be made available to you except
otherwise specified in the consent form. There are minimal risks for you in this study.
You might feel uncomfortable when you fill out the questionnaires or complete the
weekly telephone contacts. Also, the time it takes to complete the phone calls might be
inconvenient for you. You may also get tired of checking your blood sugar levels and
talking to the student investigator on the telephone at the end of each week. If school
staff asks you why you are carrying a pager with you on school property, you might feel
embarrassed or uncomfortable. The student investigator in this study will provide a letter
for you in case school staff asks you why you have a pager in school. The student
investigator and your physician at MSU/KCMS will sign this letter. Given that you will
be allowed to use the pager for personal purposes, if you choose to abuse or misuse your
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pager privileges, there may be negative consequences for you for doing so (e.g., getting
in trouble at school or with your parents). If you do abuse these privileges, your parent(s)
has the right to stop your participation in the study and to return the pager to us. One
additional risk is that your parents may stop reminding you so often about checking your
blood-glucose levels. This is not necessarily a bad outcome, if you are able to increase
your blood-glucose monitoring due to the pager intervention. However, it is possible that
by decreasing their reminders, you may forget to check your blood-glucose levels or
decrease your blood-glucose monitoring.
If you are feeling sick, you will be asked to tell your parents, call your doctor, or
go to the hospital to get medical attention. If you become distressed or upset and would
like to participate in therapy or counseling, you will be asked to tell your parents and a
referral to a mental health professional will be made.

Confidentiality o f D ata The information you provide and your answers on the

questionnaires will be kept confidential. No one other than you and your parent(s) will
be able to access this information. Your name will not be on any of the questionnaires or
forms that you complete in this study. No one other than you and your parent(s) will
have access to your pager number, unless you decide to give out your pager number to
family and friends. The student investigator will use a code number on all questionnaires
and forms. The student investigator will keep a list of names and code numbers locked up
in a room. This list will be destroyed when you are done with the study. You will also
not have to tell any of your friends why you are carrying a pager.

P articipation is Voluntary Your participation in this study is completely
voluntary. Even if you agree to participate in this study by signing this form, you can
change your mind at any time and stop participating in this study. Your decision on
whether or not to participate in this study will not jeopardize your future relations with
Western Michigan University or the medical services provided at Michigan State
University/Kalamazoo Center for Medical Studies (MSU/KCMS). You may also refuse
to answer any of the questions. If you decide to stop, the doctors and other workers at the
diabetes clinic will also not get mad at you.

Q uestions? W e will be happy to answer any of your questions. If you have any
additional questions or concerns about this study, you may call either Stephen Albrecht at
387-4485 or Dr. Amy Naugle at 387-4726. You may also contact the Chair of the
Human Subjects Institutional Review Board (387-8293) or the Vice President for
Research (387-8298) with any questions or problems that arise during this study. You
will be given a copy of this form to keep for your records.

This consent document has been approved for use for one year by the Human
Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and the
signature of the board chair in the upper right comer of all pages. Participants, including
parents or legal guardians, should not sign this document if the comer does not show a
stamped date and signature.
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YOU A RE M AK IN G A D ECISIO N W H E T H E R O R NOT TO YOU W OULD
L IK E TO PA R T IC IPA T E IN TH IS STUDY. YOUR SIGNATURE B ELO W
IN D ICA TES TH A T YOU HAVE READ TH IS FO RM , UNDERSTAND T H E
STUDY, AND HAVE DECID ED TO PA R T IC IPA T E IN TH IS STUDY.
Date___________________________________Time

Please print name here

Date

Sign name here

Date

Signature of Student Investigator Obtaining Assent

Date
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Appendix E

Office-Based Visit Instructional Script
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Office-Based Visit Instructional Script
Informed Consent:
“Thank you for your interest in this research project. Before we get started, I will first
need you to read these consent forms, which will more fully explain the purpose of this
study and the amount of time it will take for you to complete this study. There are two
separate consent forms that need to be read- one for your parents and one for you. Please
carefully read the consent forms as I review it with you and, if you are satisfied with the
conditions of the study, please sign and date both copies at the bottom. One copy of this
consent form will be returned for our records and the second copy will be for your
records. If you have any questions while reading these consent forms, I will be more than
happy to answer them.”
Administration of Questionnaires:
“Thank you for agreeing to participate in this study. Your involvement in this study is
greatly appreciated. Before we get started, I will first need you to fill out these
questionnaires. Please remember, all of your responses on these questionnaires will
remain completely confidential. If you have any questions or concerns while filling these
questionnaires out, please let me know.”
Introduction to Pagers:
“During the rest of our meeting today, we are going to fully explain the study procedures
and provide you with specific instructions and practice in how to use the pager that I will
be giving you. Before you leave today, you will receive one Motorola™ pager, like the
one that I am holding in my hand. You will not be able to keep this pager after you
complete the study. I will be providing you with your pager number during this study.
Please feel free to give your pager number out to your parents, other family members,
and friends. I will ask you to carry this pager with you at all times, including those times
when you are away from home, hanging out with friends, on trips, or in school. Here is a
letter that gives you permission to use this pager while attending school. Many high
schools do not allow students to have electronic pagers or cellular phones in school.
However, since you will have this pager for medical reasons, I will be able to get
permission for you to bring this pager to school. You will need to carry this letter with
you just in case a teacher or other school staff asks you why you have a pager in school.
Although you will be allowed to use the pager for personal reasons, we expect that you
will not abuse or misuse the paging services. For example, it is inappropriate for you to
be paged at school for reasons other than to remind you to check your blood-glucose
levels. If you misuse the pager, there may be serious consequences with your parents or
teachers. If your parents think you are misusing the pager, they have the right to stop
your participation in the study and return the pager to me. Please do not abuse or misuse
your pager privileges.”
“After you leave today, you will not receive pages right away. I will contact you by
telephone to let you know when you can expect to start receiving pages on your pager.
When I page you, you will receive a code number on your pager. Do not worry right now
if you do not know how to check and delete the messages. I will talk about how to do
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that in a few minutes. When you receive a page from me, the code number ** 4444**
or text message ***Please check your blood sugar level*** will be displayed on your
message screen. This code number will serve as a reminder for you to remember to
check your blood sugar levels 4 times per day. You might receive a page from me and
have already checked your blood sugar levels. If this happens, that’s great! You
remembered to do it without the pager reminding you to check it. However, lets say, for
example, that you receive a page around lunchtime and you haven’t checked your blood
sugar level yet. If this happens, then the page will remind you that you should check
your blood sugar levels.
“One of the most important things that you need to do each day to control your diabetes
is to closely check your blood sugar levels. We feel that it is very important for you to
closely check your blood sugar levels at least 4 times per day. The doctors here in the
diabetes clinic at MSU/KCMS have told me that you should be checking your blood
sugar levels at least four times per day, usually once before breakfast, lunch, and dinner,
and once before bedtime. You may actually have to check it more often, especially if you
are exercising or not feeling well. By closely checking your blood sugar levels each day,
you will now how well your diabetes is going. By checking your blood sugar levels at
least 4 times per day, you will be in better control of your diabetes. That’s why we are
giving you this pager. The pages that you will receive on this pager will help you to
remember to check your blood sugar levels each day. The pages are very similar to when
people write notes or reminders to themselves that they need to complete something. For
example, in order to remember a doctor’s appointment, some people might write a note
and place it on the refrigerator or in a calendar to help them remember. In school, you
may have written notes to help you remember to complete homework assignments.
Schedule of Pages:
“After you start receiving pages, I will page you everyday for about 7-weeks. Most of
the time, you will receive 4 pages per day to remind you to check your blood sugar
levels. We are going to page you once in the morning before breakfast, once before
lunchtime, once before dinnertime, and once before bedtime. In one of the questionnaires
that you completed in the beginning of our meeting today, I asked you to write down the
times in which you usually eat breakfast, lunch, and dinner, and what time you usually go
to bed each night. We will now spend a few minutes figuring out the best times for me to
page you every day. Since the times that you eat or go to bed vary from week to week,
we realize that we may not page you at the exactly right time. Towards the end of the 7
weeks, you might not receive 4 pages per day; rather, you might only get 1, 2, or 3 pages
per day. That’s OK. This does not mean that there is anything wrong with your pager.
We still want you to remember to check your blood sugar levels at least 4 times per day”
Practice Using the Pagers:
“I will now teach you how to use your pager and give you an opportunity to practice
checking and deleting pages. During this meeting, I will actually send several pages to
this pager in my hand so that you can have some practice. I also want to make sure that
you know how to answer and delete your messages. It is important to make sure that you
know how to properly use the pager before you leave today. We will also go through the
“User’s Guide” manual for your pager today. I will provide you with a copy of this
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manual in case you have any problems at home. You will also be able to contact me by
telephone if you have any problems with your pager. My phone number is on your copy
of the consent form and on the informational flier that you received in the diabetes
clinic.”
“The good news is that I have already taken the time to set-up most of the features on
your pager. However, I want to make sure that you know how to receive and read your
messages, delete your messages, and set the different alert modes. Since you will be
allowed to take this pager with you to school, we want to show you how to set the alert
mode from the audible mode to the silent alert mode (i.e., vibrating mode). That way,
your pager will not disrupt other students or make your teacher mad at school. If you set
your pager to the silent alert mode, it will be very important for you to wear your pager
with this clip or put it in your pocket. That way, you will know when you get a page.”
User’s Guide Instructional Manual:
“We will now go through this “User’s Guide Manual” [Hand Out Manual] together to
teach you how to use this pager. One of the most important things to remember is that
you should not turn off your pager at any time. Also, it is important that you remember
to delete your messages from time to time so the memory doesn’t get filled up. If you
have any questions while we go through this manual, please let me know.
1.
2.
3.
4.
5.
6.

Pager Symbols
Receiving and Reading Your Messages
Using the Function Menu
Setting the Alert Mode
Deleting Your Messages
Checking Your Battery Gauge

Telephone Contacts:
“Throughout this study, I will also be contacting you by telephone every three days or at
the end of each week. Before you start receiving pages, I will call you every three days.
At some point, I will then tell you when you will start receiving pages from me. When
you start receiving pages from me, I will then only contact you once per week. These
telephone contacts should only take about 15 to 20 minutes to complete. On one of the
questionnaires that you filled out earlier, you indicated some days and times each week
that I can get a hold of you by phone. We will now look at those times to see what you
think are the best times and days for me to call. I will try to contact you on your more
preferred day and time. If I am unable to reach you at this time and day, I will then try
another time and day until I get a hold of you. If I leave a message for you, you can call
me back and leave a message on my recorder to let me know when would be a good time
to get a hold of you.”
“During these telephone contacts, I will ask you to answer several questions over the
telephone. When I call you, you will need to have your reflectance meter with you. If
you know the time and day when I am going to call, you can make sure that your meter is
in a location where it is easy to find when I call you. If you are not home when I call
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you, I will try to call you back at another time. During this phone call, I will ask you to
check your reflectance meter while you talk with me on the phone. By looking at your
meter, you will be able to tell me how many blood sugar checks you completed during
that week. If you have more than one meter, I will need you to have both meters at home
on the day that I call you.”
3- and 6-Month Follow-Up Sessions:
“After you stop receiving pages on your pager, I will ask you and your parents to mail the
pager back to me in a box like this one. I will give you one of these boxes before you
leave today. I have already paid the postage and handling for this box. All you have to
do is place the pager in this box, seal it, and then drop it in your mailbox at home or in a
post-office mailbox. I will contact you by telephone to remind you if you forget to mail
me the pager.”
“I will also be contacting you by telephone 3 and 6 months after you finish this study.
During this telephone call, I will ask you and your parents the same questions that I asked
you while you were participating in the study. In addition, I will also ask you and your
parents to complete the same questionnaires that you filled out earlier today at the
beginning of this meeting. Because you and your parents will not have a copy of these
questionnaires, I will read them to you over the phone and you will tell me the answers.”
Wrap-Up:
“We have finished everything that we need to cover today. Remember, I will be calling
you in three days to talk with you on the telephone. I will let you know when you will
start receiving the pages. Thanks again for your willingness to participate in this study.
If you have any questions or concerns, you can call me at the phone number listed on
your copy of the informed consent form. My number is also located on the flier that you
received in the diabetes clinic.”
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Weekly Participant Phone Contact Script - Baseline and Intervention Phases
“H ello ,_________________________ . This is Steve Albrecht calling from
MSU/KCMS. [Establish Rapport] I am calling you today because we agreed that I
would contact you to find out how many times you checked your blood sugar levels [over
the past three days] each week. I will also ask you some questions about how you are
doing with other diabetes self-care activities. This should take only about 15 minutes to
complete. Do you have your reflectance meter with you right now? Before we can get
started, you will need your reflectance meter. If you don’t have your reflectance meter, I
can wait here on the phone while you go and find it.
O.K. Now that you have your meter, I will need you to report how many times
you have checked your blood sugar levels [over the past three days] over the past week. I
will need you to tell me the time and date of each test and the actual blood sugar reading
for each test. Let’s start at the beginning of the week [with the day of our last
conversation] and we will go over each day one at a time. Please tell me the number of
times that you checked your blood sugar levels and your readings o n ____________ _____
(Date). O.K. Lets check the next day. [Repeat Procedure]
“I am now going to ask you several questions about how well you’ve completed certain
diabetes self-care activities [during the past 3 days] during the past 7 days. When I ask
you a question, please try to think about how well you have done [over the past 3 days]
over the past 7 days. I will ask you to tell me how many days [over the past 3 days] this
week you completed the activity. Please take your time and try to remember everything.
If you have any questions, please let me know.”
“That is all the questions that I have for you today. Do you have any questions or
concerns about the study? Please remember that I will be calling you again i n _________
_____________(days). Thanks for your time and I will talk with you again [in three days]
next week. Have a great week!

116

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix G

Data Collection Forms
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Tuesday

Wednesday

Thursday

Friday

Saturday

Sunday

Date
C heck# 1- Time
Blood Glucose Reading
Check # 2- Time
Blood Glucose Reading
Check # 3- Time
Blood Glucose Reading
Check # 4- Time
Blood Glucose Reading
Check # 5- Time
Blood Glucose Reading
Check # 6- Time
Blood Glucose Reading
C heck# 7- Time
Blood Glucose Reading
Check # 8- Time
Blood Glucose Reading
Check # 9- Time
Blood Glucose Reading
Check # 1 0 - Time
Blood Glucose Reading

Data Collection Form 1 - Blood Glucose Monitoring
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Mondav

Data Collection Form 2 - Diabetes Self-Care Activities
Diet Questions
1. How many days this week did you choose to eat healthy foods?
2. How many days this week did you eat five or more servings of fruits
and vegetables?
3. How many days this week did you eat foods that were high in fat or
salt, such as
red meat, pizza, fast food, or salad dressings?
4. How many days this week did you follow your eating plan?
5. How many days this week did you eat the right amount of food?
6. How many days this week did you eat your meals at the right time?
7. How many days this week did you eat six meals or snacks per day?
Exercise Questions
8. How many days this week did you participate in at least 30 minutes of
physical activity, such as walking or working in the yard?
How many days this week did you participate in a specific type of
exercise,such as working out in the gym, jogging, swimming, or
biking?
Insulin/Medication Questions
How many days this week did you take your recommended number of
insulin injections?
11. How many days this week did you take your insulin injections at the
right time?
12. How many days this week did you take your recommended pill
medications?
Foot Care Questions
13. How many days this week did you check your feet?
14. How many days this week did you wash your feet?
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Days (1-7)

Data Collection Form 3 - Medical Chart Review

Subject Number:
Baseline Start Date:
Intervention Start Date:
Week Number:
Date:
Current Age:
Type of Diagnosis:
Age of Diagnosis:
Number of Hospitalizations:
(Previous Year)
Types of Medications:
Insulin Dose:

Average number of blood glucose checks performed at 3-month intervals
Ml

M2

M3

M4

M5

M6

Date
Range:
Average
Number
of Blood
Glucose
Checks:
* Note: M=Month
Available hemoglobin A ic levels at 3-month intervals
3-Months

6-Months

9-Months

12-Months

Date Range:
HbAic Values:
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Letter to School
Dear School Staff:
I am a graduate student in a doctoral program in clinical psychology at Western Michigan
University. I am currently conducting my dissertation study entitled “An Office-Based
Intervention to Improve Blood Glucose Monitoring in Adolescents with InsulinDependent Diabetes Mellitus.” This study is investigating whether or not a treatment is
effective in improving blood glucose monitoring in teenagers with diabetes. The Human
Subjects Institutional Review Board (HSIRB) at Western Michigan University (WMU)
has granted me permission to conduct this study.
We are providing participants in this study with an electronic pager. I will be paging
participants four times daily to remind them to check their blood glucose levels
throughout the day. We are asking all participants to carry this electronic pager with
them at all times, including those times when they are in school. We are also asking all
students to set their pager to the silent mode so that it does not disrupt the classroom
environment.
Although current state laws restrict all students from carrying a pager, cell phone, or
other electronic devices within the school setting, it also provides several exemptions for
students with chronic medical conditions. This letter provides an explanation for why
this adolescent is using the electronic pager within the school setting. If you have any
questions or concerns, please feel free to contact me at (616) 337-6459. I would be more
than happy to answer any questions or concerns that you might have.
Sincerely,

Stephen J. Albrecht, MA
MSU/KCMS

Martin Draznin, MD
MSU/KCMS

122

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix I

Figures

123

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Meter

Baseline

Intervention

Baseline

100
--------------------

90

‘A

80

•— •

•— •

1.
,/*
Fading

70
60
50
40 30
20

-

10

-

Megan

Weekly Percentage Adherence Rate

0-

Meter

Intervention

Baseline

Meter
100
90
80
70
60
50
40
30
20
10
0

Intervention
•

-

-

•—

-

Debra

Weeks

Figure 1. Percentage adherence to blood glucose monitoring checks across study
conditions for Megan (top panel), Sara (middle panel), and Debra (bottom panel).
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Figure 2. Percentage adherence to blood glucose monitoring checks across study
conditions for Robert (top panel), Susan (middle panel), and Gretchen (bottom panel).
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Figure 3. Mean 7-day blood glucose readings across study conditions for Megan (top
panel), Sara (middle panel), and Susan (bottom panel). The horizontal line represents the
participant’s average blood glucose level (based on the participant’s hemoglobin A [c
value) in the 2- to 3-months before study entry.
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y !

IC H K j A N UiNiVfci < b i i y
Human Subjects Institutional Review Board

e n te n m a l
1903-2003 C e le b r a tio n

Date: July 30,2002
To:

Amy Naugle, Principal Investigator
Stephen Albrecht, Student Investigator for dissertation

From: Mary Lagerwey, Chair ^
Re:

x

HSIRB Project Number: 02-07-04

This letter w ill confirm that your research project entitled “An Office-Based Intervention
to Improve Blood Glucose Monitoring in Adolescents with Insulin-Dependent Diabetes
Mellitus” has been approved under the full category o f review by the Human Subjects
Institutional Review Board. The conditions and duration o f this approval are specified in
the Policies o f Western Michigan University. You may now begin to implement the
research as described in the application.
Please note that you may only conduct this research exactly in the form it was approved.
You must seek specific board approval for any changes in this project. You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct o f this research, you should immediately suspend the project
and contact the Chair o f the HSIRB for consultation.
The Board wishes you success in the pursuit o f your research goals.

Approval Termination:

July 17,2003

W alwood H all, K alam azoo Ml 4 9 0 0 8 -5 4 5 6
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